CEO.CA SEDI filings for

SEDI Insider filing browser

Date	Issuer	Insider	Transaction	Amount	New Balance ⓘ The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-04-05 10:06 Tx date 2024-03-21	$IPA ImmunoPrecise Antibodies Ltd.	Levine, Mitchell 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$14,256 +10,000 vol $1.43 each	20,000
Filed 2024-03-27 17:41 Tx date 2024-03-27	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$6,567 +4,211 vol $1.56 each	248,818
Filed 2024-03-27 17:40 Tx date 2024-03-27	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$78.50 +50 vol $1.57 each	244,607
Filed 2024-03-27 17:39 Tx date 2024-03-27	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,152 +739 vol $1.56 each	244,557
Filed 2024-03-27 10:26 Tx date 2024-03-26	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,554 +3,000 vol $1.52 each	243,818
Filed 2024-03-27 10:25 Tx date 2024-03-25	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,538 +1,000 vol $1.54 each	240,818
Filed 2024-03-26 15:39 Tx date 2024-03-26	$IPA ImmunoPrecise Antibodies Ltd.	Taylor, Kristin 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$7,649 +5,000 vol $1.53 each	10,000
Filed 2024-03-25 10:02 Tx date 2024-03-22	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,469 +3,000 vol $1.49 each	239,818
Filed 2024-03-22 15:30 Tx date 2024-03-21	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,140 +3,000 vol $1.38 each	236,818
Filed 2024-03-22 15:29 Tx date 2024-03-21	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$7,000 +5,000 vol $1.40 each	233,818
Filed 2024-03-22 15:28 Tx date 2024-03-21	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,408 +1,000 vol $1.41 each	228,818
Filed 2024-03-22 11:45 Tx date 2024-01-02	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report		8,045
Filed 2024-03-21 11:04 Tx date 2024-03-18	$IPA ImmunoPrecise Antibodies Ltd.	Roodink, Ilse 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$285.58 +200 vol $1.43 each	9,542
Filed 2024-03-21 11:03 Tx date 2024-03-18	$IPA ImmunoPrecise Antibodies Ltd.	Roodink, Ilse 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$286.00 +200 vol $1.43 each	9,342
Filed 2024-03-21 11:03 Tx date 2024-03-18	$IPA ImmunoPrecise Antibodies Ltd.	Roodink, Ilse 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$7,540 +5,200 vol $1.45 each	9,142
Filed 2024-01-25 11:27 Tx date 2024-01-19	$IPA ImmunoPrecise Antibodies Ltd.	Springer, Barry Alan 4 - Director of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$29,600 +20,000 vol $1.48 each	60,000
Filed 2024-01-25 11:26 Tx date 2024-01-19	$IPA ImmunoPrecise Antibodies Ltd.	Buyse, Chris 4 - Director of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$29,600 +20,000 vol $1.48 each	60,000
Filed 2024-01-25 11:25 Tx date 2024-01-19	$IPA ImmunoPrecise Antibodies Ltd.	Witters, Dirk 4 - Director of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$29,600 +20,000 vol $1.48 each	60,000
Filed 2024-01-25 11:23 Tx date 2024-01-19	$IPA ImmunoPrecise Antibodies Ltd.	Levine, Mitchell 4 - Director of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$29,600 +20,000 vol $1.48 each	60,000
Filed 2024-01-25 11:08 Tx date 2024-01-19	$IPA ImmunoPrecise Antibodies Ltd.	Levine, Mitchell 4 - Director of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$59,200 +40,000 vol $1.48 each	40,000
Filed 2024-01-25 11:07 Tx date 2023-11-09	$IPA ImmunoPrecise Antibodies Ltd.	Levine, Mitchell 4 - Director of Issuer Direct Ownership	Options Stock Options 00 - Opening Balance-Initial SEDI Report
Filed 2024-01-25 11:05 Tx date 2024-01-19	$IPA ImmunoPrecise Antibodies Ltd.	Buyse, Chris 4 - Director of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$59,200 +40,000 vol $1.48 each	40,000
Filed 2024-01-25 11:04 Tx date 2023-09-01	$IPA ImmunoPrecise Antibodies Ltd.	Buyse, Chris 4 - Director of Issuer Direct Ownership	Options Stock Options 00 - Opening Balance-Initial SEDI Report
Filed 2024-01-25 11:00 Tx date 2024-01-19	$IPA ImmunoPrecise Antibodies Ltd.	Springer, Barry Alan 4 - Director of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$59,200 +40,000 vol $1.48 each	40,000
Filed 2024-01-25 10:59 Tx date 2023-09-01	$IPA ImmunoPrecise Antibodies Ltd.	Springer, Barry Alan 4 - Director of Issuer Direct Ownership	Options Stock Options 00 - Opening Balance-Initial SEDI Report
Filed 2024-01-25 10:55 Tx date 2024-01-19	$IPA ImmunoPrecise Antibodies Ltd.	Witters, Dirk 4 - Director of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$59,200 +40,000 vol $1.48 each	40,000
Filed 2024-01-25 10:39 Tx date 2023-09-01	$IPA ImmunoPrecise Antibodies Ltd.	Witters, Dirk 4 - Director of Issuer Direct Ownership	Options Stock Options 00 - Opening Balance-Initial SEDI Report
Filed 2024-01-09 11:59 Tx date 2023-12-08	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 15 - Acquisition or disposition under a prospectus	$20,000 +20,000 vol $1.00 each	225,818
Filed 2023-12-27 11:19 Tx date 2023-12-08	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$20,000 +20,000 vol $1.00 each
Filed 2023-12-27 11:19 Tx date 2023-12-08	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$20,000 +20,000 vol $1.00 each	225,818
Filed 2023-12-21 09:39 Tx date 2023-12-20	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,698 +2,000 vol $1.35 each	207,818
Filed 2023-12-20 10:17 Tx date 2023-12-18	$IPA ImmunoPrecise Antibodies Ltd.	Levine, Mitchell 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$13,834 +10,000 vol $1.38 each	10,000
Filed 2023-12-20 10:15 Tx date 2023-11-09	$IPA ImmunoPrecise Antibodies Ltd.	Levine, Mitchell 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2023-11-13 05:48 Tx date 2023-11-09	$IPA ImmunoPrecise Antibodies Ltd.	Witters, Dirk 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,700 +1,000 vol $1.70 each	1,950
Filed 2023-11-03 13:54 Tx date 2023-11-01	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,066 +1,000 vol $2.07 each	205,818
Filed 2023-10-31 06:39 Tx date 2023-10-27	$IPA ImmunoPrecise Antibodies Ltd.	Witters, Dirk 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,729 +950 vol $1.82 each	950
Filed 2023-10-26 15:05 Tx date 2023-10-23	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,115 +900 vol $1.24 each	204,818
Filed 2023-10-26 15:03 Tx date 2023-10-23	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$123.00 +100 vol $1.23 each	203,918
Filed 2023-10-26 15:02 Tx date 2023-10-23	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$123.10 +100 vol $1.23 each	203,818
Filed 2023-10-26 15:01 Tx date 2023-10-23	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$123.00 +100 vol $1.23 each	203,718
Filed 2023-10-26 15:00 Tx date 2023-10-23	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$123.00 +100 vol $1.23 each	203,618
Filed 2023-10-26 15:00 Tx date 2023-10-23	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$246.00 +200 vol $1.23 each	203,518
Filed 2023-10-26 14:58 Tx date 2023-10-23	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$123.00 +100 vol $1.23 each	203,118
Filed 2023-10-26 14:56 Tx date 2023-10-23	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$123.00 +100 vol $1.23 each	203,018
Filed 2023-10-26 14:55 Tx date 2023-10-23	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$123.00 +100 vol $1.23 each	202,918
Filed 2023-10-26 12:51 Tx date 2023-10-26	$IPA ImmunoPrecise Antibodies Ltd.	Taylor, Kristin 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$6,750 +5,000 vol $1.35 each	5,000
Filed 2023-10-26 12:50 Tx date 2023-09-18	$IPA ImmunoPrecise Antibodies Ltd.	Taylor, Kristin 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2023-10-26 10:19 Tx date 2023-10-25	$IPA ImmunoPrecise Antibodies Ltd.	Springer, Barry Alan 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$14,090 +10,000 vol $1.41 each	10,000
Filed 2023-10-19 11:48 Tx date 2023-10-16	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,320 +1,000 vol $1.32 each	202,818
Filed 2023-10-03 14:23 Tx date 2023-10-02	$IPA ImmunoPrecise Antibodies Ltd.	Roodink, Ilse 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$176.00 +100 vol $1.76 each	3,942
Filed 2023-10-03 14:23 Tx date 2023-10-02	$IPA ImmunoPrecise Antibodies Ltd.	Roodink, Ilse 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$184.80 +105 vol $1.76 each	3,842
Filed 2023-10-03 14:22 Tx date 2023-10-02	$IPA ImmunoPrecise Antibodies Ltd.	Roodink, Ilse 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$600.16 +341 vol $1.76 each	3,737
Filed 2023-10-03 14:22 Tx date 2023-10-02	$IPA ImmunoPrecise Antibodies Ltd.	Roodink, Ilse 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$10.56 +6 vol $1.76 each	3,396
Filed 2023-10-03 14:21 Tx date 2023-10-02	$IPA ImmunoPrecise Antibodies Ltd.	Roodink, Ilse 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$84.48 +48 vol $1.76 each	3,390
Filed 2023-09-25 09:44 Tx date 2023-09-22	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,980 +1,000 vol $1.98 each	201,818
Filed 2023-09-18 11:25 Tx date 2023-09-18	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,890 +1,000 vol $1.89 each	200,818
Filed 2023-09-13 15:49 Tx date 2023-09-01	$IPA ImmunoPrecise Antibodies Ltd.	Springer, Barry Alan 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2023-09-13 15:33 Tx date 2023-09-01	$IPA ImmunoPrecise Antibodies Ltd.	Witters, Dirk 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2023-09-13 15:09 Tx date 2023-09-01	$IPA ImmunoPrecise Antibodies Ltd.	Buyse, Chris 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2023-06-01 14:57 Tx date 2023-05-22	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$298.27 +100 vol $2.98 each	199,818
Filed 2023-06-01 14:56 Tx date 2023-05-22	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,516 +850 vol $2.96 each	199,718
Filed 2023-04-20 11:05 Tx date 2023-04-20	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,800 +1,000 vol $2.80 each	27,209
Filed 2023-04-06 14:06 Tx date 2023-04-06	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,960 +2,000 vol $2.48 each	26,209
Filed 2023-04-04 14:27 Tx date 2023-04-03	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$516.00 +200 vol $2.58 each	198,868
Filed 2023-04-04 14:26 Tx date 2023-04-03	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$518.00 +200 vol $2.59 each	198,668
Filed 2023-04-04 14:24 Tx date 2023-04-03	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$633.60 +240 vol $2.64 each	198,468
Filed 2023-04-03 09:12 Tx date 2023-03-30	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,872 +1,000 vol $2.87 each	198,228
Filed 2023-04-03 09:11 Tx date 2023-03-28	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-111,400 -40,000 vol $2.79 each	20,370
Filed 2023-03-28 10:08 Tx date 2023-03-27	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$672.75 +230 vol $2.92 each	197,228
Filed 2023-03-28 10:07 Tx date 2023-03-22	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,251 +400 vol $3.13 each	196,998
Filed 2023-03-28 10:07 Tx date 2023-03-20	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$334.00 +100 vol $3.34 each	196,598
Filed 2023-03-23 14:06 Tx date 2023-03-17	$IPA ImmunoPrecise Antibodies Ltd.	Kuo, James 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$974.91 +300 vol $3.25 each	25,500
Filed 2023-03-23 14:06 Tx date 2023-03-17	$IPA ImmunoPrecise Antibodies Ltd.	Kuo, James 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$648.02 +200 vol $3.24 each	25,200
Filed 2023-03-21 16:12 Tx date 2023-03-21	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,808 +605 vol $2.99 each	24,209
Filed 2023-03-21 16:11 Tx date 2023-03-21	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,177 +395 vol $2.98 each	23,604
Filed 2023-03-20 14:35 Tx date 2023-03-20	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$3,220 +1,000 vol $3.22 each	23,209
Filed 2023-03-20 10:05 Tx date 2023-03-17	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$968.46 +300 vol $3.23 each	196,498
Filed 2023-03-20 10:04 Tx date 2023-03-17	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$650.00 +200 vol $3.25 each	196,198
Filed 2023-03-20 10:02 Tx date 2023-03-17	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$482.89 +150 vol $3.22 each	195,998
Filed 2023-02-26 01:14 Tx date 2023-02-19	$IPA ImmunoPrecise Antibodies Ltd.	McConn, Brad 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$245,999 +60,000 vol $4.10 each	102,000
Filed 2023-02-26 01:12 Tx date 2023-02-19	$IPA ImmunoPrecise Antibodies Ltd.	Roodink, Ilse 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$164,000 +40,000 vol $4.10 each	105,000
Filed 2023-02-26 01:10 Tx date 2023-02-19	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$1,231,853 +300,452 vol $4.10 each	700,452
Filed 2023-02-26 01:08 Tx date 2023-02-19	$IPA ImmunoPrecise Antibodies Ltd.	Duplantis, Barry Neil 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$204,999 +50,000 vol $4.10 each	77,000
Filed 2023-02-26 01:06 Tx date 2023-02-19	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$1,231,853 +300,452 vol $4.10 each
Filed 2023-02-24 09:45 Tx date 2023-02-19	$IPA ImmunoPrecise Antibodies Ltd.	Anderson-Helbling, Lisa 4 - Director of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$29,786 +7,265 vol $4.10 each	112,265
Filed 2023-02-24 09:36 Tx date 2023-02-19	$IPA ImmunoPrecise Antibodies Ltd.	Burke, Robert 4 - Director of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$29,786 +7,265 vol $4.10 each	52,265
Filed 2023-02-23 17:15 Tx date 2022-12-13	$IPA ImmunoPrecise Antibodies Ltd.	Anderson-Helbling, Lisa 4 - Director of Issuer Direct Ownership	Options Stock Options 00 - Opening Balance-Initial SEDI Report		105,000
Filed 2023-02-23 17:13 Tx date 2022-12-13	$IPA ImmunoPrecise Antibodies Ltd.	Anderson-Helbling, Lisa 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report		2,000
Filed 2023-02-22 23:13 Tx date 2023-02-17	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$483.00 +120 vol $4.03 each	195,848
Filed 2023-02-22 23:12 Tx date 2023-02-17	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$408.00 +100 vol $4.08 each	195,728
Filed 2023-02-10 23:59 Tx date 2023-02-07	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$199,308 +84,812 vol $2.35 each	195,628
Filed 2023-02-10 23:59 Tx date 2023-02-07	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 51 - Exercise of options	$-329,000 -140,000 vol $2.35 each	400,000
Filed 2023-02-10 23:53 Tx date 2023-02-07	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$199,308 +84,812 vol $2.35 each
Filed 2023-02-10 23:51 Tx date 2023-02-07	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$199,308 +84,812 vol $2.35 each
Filed 2023-01-04 12:41 Tx date 2023-01-03	$IPA ImmunoPrecise Antibodies Ltd.	Smith, Gregory Stuart 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$97,500 +30,000 vol $3.25 each	72,500
Filed 2023-01-04 12:40 Tx date 2023-01-03	$IPA ImmunoPrecise Antibodies Ltd.	Smith, Gregory Stuart 4 - Director of Issuer Direct Ownership	Options Stock Options 51 - Exercise of options	$-97,500 -30,000 vol $3.25 each	15,000
Filed 2022-12-19 10:24 Tx date 2022-12-16	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,401 +490 vol $4.90 each	110,816
Filed 2022-12-19 10:23 Tx date 2022-12-16	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,550 +510 vol $5.00 each	110,326
Filed 2022-12-19 10:21 Tx date 2022-12-16	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,915 +1,000 vol $4.92 each	109,816
Filed 2022-11-08 11:53 Tx date 2022-11-04	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$966.00 +200 vol $4.83 each	108,816
Filed 2022-11-08 11:52 Tx date 2022-11-03	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$471.00 +100 vol $4.71 each	108,616
Filed 2022-11-08 11:52 Tx date 2022-11-03	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$473.00 +100 vol $4.73 each	108,516
Filed 2022-11-08 10:55 Tx date 2022-11-08	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$966.00 +200 vol $4.83 each	108,816
Filed 2022-11-08 10:55 Tx date 2022-11-08	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$966.00 +200 vol $4.83 each
Filed 2022-11-08 10:54 Tx date 2022-11-07	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$471.00 +100 vol $4.71 each	108,616
Filed 2022-11-08 10:54 Tx date 2022-11-07	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$471.00 +100 vol $4.71 each
Filed 2022-11-08 10:53 Tx date 2022-11-07	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$473.00 +100 vol $4.73 each
Filed 2022-11-08 10:53 Tx date 2022-11-07	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$473.00 +100 vol $4.73 each	108,516
Filed 2022-10-31 09:57 Tx date 2022-10-19	$IPA ImmunoPrecise Antibodies Ltd.	Vézina, Sébastien 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2022-10-06 12:51 Tx date 2022-09-29	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$783.82 +200 vol $3.92 each	108,416
Filed 2022-10-06 12:46 Tx date 2022-09-28	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$391.00 +100 vol $3.91 each	107,016
Filed 2022-10-06 12:43 Tx date 2022-09-27	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,454 +600 vol $4.09 each	106,916
Filed 2022-10-06 12:43 Tx date 2022-09-27	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,636 +400 vol $4.09 each	106,316
Filed 2022-10-06 12:42 Tx date 2022-09-29	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$783.82 +200 vol $3.92 each
Filed 2022-10-06 12:42 Tx date 2022-09-29	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$389.00 +100 vol $3.89 each	108,216
Filed 2022-10-06 12:41 Tx date 2022-09-29	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$388.90 +100 vol $3.89 each	108,116
Filed 2022-10-06 12:41 Tx date 2022-09-29	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$385.00 +100 vol $3.85 each	108,016
Filed 2022-10-06 12:40 Tx date 2022-09-29	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$388.27 +100 vol $3.88 each	107,916
Filed 2022-10-06 12:40 Tx date 2022-09-29	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,166 +300 vol $3.89 each	107,816
Filed 2022-10-06 12:39 Tx date 2022-09-29	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,156 +300 vol $3.85 each	107,516
Filed 2022-10-06 12:38 Tx date 2022-09-29	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$789.80 +200 vol $3.95 each	107,216
Filed 2022-09-26 11:03 Tx date 2022-09-23	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$72.00 +18 vol $4.00 each	105,916
Filed 2022-09-26 11:02 Tx date 2022-09-23	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$992.20 +242 vol $4.10 each	105,898
Filed 2022-09-26 11:02 Tx date 2022-09-23	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$237.80 +58 vol $4.10 each	105,656
Filed 2022-09-26 11:01 Tx date 2022-09-23	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$410.00 +100 vol $4.10 each	105,598
Filed 2022-09-26 11:01 Tx date 2022-09-23	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$410.00 +100 vol $4.10 each	105,498
Filed 2022-09-26 11:00 Tx date 2022-09-23	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$891.00 +220 vol $4.05 each	105,398
Filed 2022-09-26 11:00 Tx date 2022-09-23	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,134 +280 vol $4.05 each	105,178
Filed 2022-09-26 10:59 Tx date 2022-09-23	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$420.00 +100 vol $4.20 each	104,898
Filed 2022-09-26 10:59 Tx date 2022-09-23	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$7,980 +1,900 vol $4.20 each	104,798
Filed 2022-09-26 10:58 Tx date 2022-09-23	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,315 +1,000 vol $4.32 each	102,898
Filed 2022-09-26 10:56 Tx date 2022-09-23	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,182 +500 vol $4.36 each	101,898
Filed 2022-09-26 09:56 Tx date 2022-09-20	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$503.05 +100 vol $5.03 each	98,098
Filed 2022-09-26 09:56 Tx date 2022-09-22	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$149.76 +32 vol $4.68 each	101,398
Filed 2022-09-26 09:55 Tx date 2022-09-22	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$318.24 +68 vol $4.68 each	101,366
Filed 2022-09-26 09:55 Tx date 2022-09-22	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$459.99 +100 vol $4.60 each	101,298
Filed 2022-09-26 09:54 Tx date 2022-09-22	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$395.59 +86 vol $4.60 each	101,198
Filed 2022-09-26 09:54 Tx date 2022-09-22	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,456 +314 vol $4.64 each	101,112
Filed 2022-09-26 09:53 Tx date 2022-09-22	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,314 +500 vol $4.63 each	100,798
Filed 2022-09-26 09:53 Tx date 2022-09-22	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,277 +500 vol $4.55 each	100,298
Filed 2022-09-26 09:52 Tx date 2022-09-22	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$458.90 +100 vol $4.59 each	99,798
Filed 2022-09-26 09:52 Tx date 2022-09-22	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$458.97 +100 vol $4.59 each	99,698
Filed 2022-09-26 09:51 Tx date 2022-09-22	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$459.00 +100 vol $4.59 each	99,598
Filed 2022-09-26 09:51 Tx date 2022-09-22	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$459.00 +100 vol $4.59 each	99,498
Filed 2022-09-26 09:50 Tx date 2022-09-22	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$459.00 +100 vol $4.59 each	99,398
Filed 2022-09-26 09:50 Tx date 2022-09-22	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,327 +500 vol $4.65 each	99,298
Filed 2022-09-26 09:49 Tx date 2022-09-22	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,329 +500 vol $4.66 each	98,798
Filed 2022-09-26 09:48 Tx date 2022-09-21	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$500.00 +100 vol $5.00 each	98,298
Filed 2022-09-26 09:47 Tx date 2022-09-21	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$503.34 +100 vol $5.03 each	98,198
Filed 2022-09-23 15:51 Tx date 2022-09-23	$IPA ImmunoPrecise Antibodies Ltd.	Smith, Gregory Stuart 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$18,935 +3,500 vol $5.41 each	42,500
Filed 2022-09-16 11:02 Tx date 2022-09-15	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,456 +300 vol $4.85 each	97,998
Filed 2022-09-16 11:02 Tx date 2022-09-15	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,489 +500 vol $4.98 each	97,698
Filed 2022-09-16 11:01 Tx date 2022-09-15	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,486 +300 vol $4.96 each	97,198
Filed 2022-09-16 11:01 Tx date 2022-09-15	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$279.87 +57 vol $4.91 each	96,898
Filed 2022-09-16 11:01 Tx date 2022-09-15	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$702.13 +143 vol $4.91 each	96,841
Filed 2022-09-16 11:00 Tx date 2022-09-15	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$493.00 +100 vol $4.93 each	96,698
Filed 2022-09-16 11:00 Tx date 2022-09-15	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$493.00 +100 vol $4.93 each	96,598
Filed 2022-09-16 10:59 Tx date 2022-09-15	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$746.64 +153 vol $4.88 each	96,498
Filed 2022-09-16 10:59 Tx date 2022-09-15	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$229.36 +47 vol $4.88 each	96,345
Filed 2022-09-16 10:58 Tx date 2022-09-15	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$863.76 +177 vol $4.88 each	96,298
Filed 2022-09-16 10:58 Tx date 2022-09-15	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$112.24 +23 vol $4.88 each	96,121
Filed 2022-09-16 10:57 Tx date 2022-09-15	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$976.00 +200 vol $4.88 each	96,098
Filed 2022-09-16 10:57 Tx date 2022-09-15	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$499.00 +100 vol $4.99 each	95,898
Filed 2022-09-16 10:56 Tx date 2022-09-15	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$844.98 +169 vol $5.00 each	95,798
Filed 2022-09-16 10:56 Tx date 2022-09-15	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$3,434 +687 vol $5.00 each	95,629
Filed 2022-09-16 10:55 Tx date 2022-09-15	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$220.00 +44 vol $5.00 each	94,942
Filed 2022-09-16 09:02 Tx date 2022-09-15	$IPA ImmunoPrecise Antibodies Ltd.	McConn, Brad 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$19,902 +4,000 vol $4.98 each	8,000
Filed 2022-08-18 16:24 Tx date 2022-08-17	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,915 +500 vol $5.83 each	94,898
Filed 2022-08-18 16:23 Tx date 2022-08-17	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,149 +200 vol $5.75 each	94,398
Filed 2022-08-18 16:23 Tx date 2022-08-16	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,085 +200 vol $5.43 each	94,198
Filed 2022-08-18 16:22 Tx date 2022-08-16	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,074 +200 vol $5.37 each	93,998
Filed 2022-08-18 08:56 Tx date 2022-08-17	$IPA ImmunoPrecise Antibodies Ltd.	Burke, Robert 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$7,310 +1,000 vol $7.31 each	31,000
Filed 2022-08-16 14:44 Tx date 2022-08-10	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$479.50 +100 vol $4.79 each	90,698
Filed 2022-08-16 14:43 Tx date 2022-08-10	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$479.50 +100 vol $4.79 each	90,598
Filed 2022-08-16 14:43 Tx date 2022-08-10	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$479.50 +100 vol $4.79 each	90,498
Filed 2022-08-16 14:42 Tx date 2022-08-10	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$479.50 +100 vol $4.79 each	90,398
Filed 2022-08-16 14:41 Tx date 2022-08-10	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$484.00 +100 vol $4.84 each	90,298
Filed 2022-08-16 14:41 Tx date 2022-08-10	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$484.00 +100 vol $4.84 each	90,198
Filed 2022-08-16 14:41 Tx date 2022-08-10	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,407 +500 vol $4.82 each	90,098
Filed 2022-08-16 14:40 Tx date 2022-08-10	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,420 +296 vol $4.80 each	89,598
Filed 2022-08-16 14:39 Tx date 2022-08-10	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$979.20 +204 vol $4.80 each	89,302
Filed 2022-08-16 14:39 Tx date 2022-08-10	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,463 +300 vol $4.88 each	89,098
Filed 2022-08-16 14:38 Tx date 2022-08-12	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,410 +800 vol $5.51 each	93,298
Filed 2022-08-16 14:38 Tx date 2022-08-12	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,096 +200 vol $5.48 each	92,498
Filed 2022-08-16 14:37 Tx date 2022-08-12	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$549.99 +100 vol $5.50 each	92,298
Filed 2022-08-16 14:37 Tx date 2022-08-12	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$550.00 +100 vol $5.50 each	92,198
Filed 2022-08-16 14:36 Tx date 2022-08-12	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$66.00 +12 vol $5.50 each	92,098
Filed 2022-08-16 14:36 Tx date 2022-08-12	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$484.00 +88 vol $5.50 each	92,086
Filed 2022-08-16 14:35 Tx date 2022-08-12	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,668 +300 vol $5.56 each	91,998
Filed 2022-08-16 14:35 Tx date 2022-08-12	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$3,347 +600 vol $5.58 each	91,698
Filed 2022-08-16 14:34 Tx date 2022-08-12	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,210 +400 vol $5.53 each	91,098
Filed 2022-08-16 14:33 Tx date 2022-08-15	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$529.50 +100 vol $5.29 each	93,798
Filed 2022-08-16 14:32 Tx date 2022-08-15	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$534.10 +100 vol $5.34 each	93,698
Filed 2022-08-16 14:31 Tx date 2022-08-15	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,071 +200 vol $5.36 each	93,598
Filed 2022-08-16 14:30 Tx date 2022-08-15	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$545.56 +100 vol $5.46 each	93,398
Filed 2022-08-15 19:06 Tx date 2022-08-15	$IPA ImmunoPrecise Antibodies Ltd.	Smith, Gregory Stuart 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$34,670 +5,000 vol $6.93 each	39,000
Filed 2022-08-15 16:09 Tx date 2022-08-15	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$692.00 +100 vol $6.92 each	60,370
Filed 2022-08-15 16:08 Tx date 2022-08-15	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$2,744 +400 vol $6.86 each	60,270
Filed 2022-08-12 14:19 Tx date 2022-08-12	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$718.00 +100 vol $7.18 each	59,870
Filed 2022-08-12 14:18 Tx date 2022-08-12	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$719.00 +100 vol $7.19 each	59,770
Filed 2022-08-12 14:18 Tx date 2022-08-12	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$2,157 +300 vol $7.19 each	59,670
Filed 2022-08-12 14:18 Tx date 2022-08-12	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$719.00 +100 vol $7.19 each	59,370
Filed 2022-08-12 14:17 Tx date 2022-08-12	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$718.00 +100 vol $7.18 each	59,270
Filed 2022-08-12 14:17 Tx date 2022-08-12	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$717.00 +100 vol $7.17 each	59,170
Filed 2022-08-12 14:17 Tx date 2022-08-12	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$716.00 +100 vol $7.16 each	59,070
Filed 2022-08-12 14:16 Tx date 2022-08-12	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$1,420 +200 vol $7.10 each	58,970
Filed 2022-08-12 14:15 Tx date 2022-08-11	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$651.00 +100 vol $6.51 each	58,770
Filed 2022-08-12 14:15 Tx date 2022-08-11	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$5,208 +800 vol $6.51 each	58,670
Filed 2022-08-11 10:07 Tx date 2022-08-09	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$435.21 +100 vol $4.35 each	88,798
Filed 2022-08-11 10:06 Tx date 2022-08-09	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,304 +300 vol $4.35 each	88,698
Filed 2022-08-11 10:05 Tx date 2022-08-09	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,686 +400 vol $4.22 each	88,398
Filed 2022-08-11 10:04 Tx date 2022-08-09	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,224 +295 vol $4.15 each	87,998
Filed 2022-08-11 10:03 Tx date 2022-08-09	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$20.95 +5 vol $4.19 each	87,703
Filed 2022-08-10 11:46 Tx date 2022-08-10	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$575.00 +100 vol $5.75 each	57,870
Filed 2022-08-10 11:46 Tx date 2022-08-10	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$2,300 +400 vol $5.75 each	57,770
Filed 2022-08-10 11:45 Tx date 2022-08-10	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$4,592 +800 vol $5.74 each	57,370
Filed 2022-08-10 11:45 Tx date 2022-08-10	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$3,450 +600 vol $5.75 each	56,570
Filed 2022-08-10 11:44 Tx date 2022-08-10	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$7,980 +1,400 vol $5.70 each	55,970
Filed 2022-08-10 11:05 Tx date 2022-08-09	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$550.00 +100 vol $5.50 each	54,570
Filed 2022-08-10 11:05 Tx date 2022-08-09	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$550.00 +100 vol $5.50 each	54,470
Filed 2022-08-10 11:04 Tx date 2022-08-09	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$2,750 +500 vol $5.50 each	54,370
Filed 2022-08-08 09:50 Tx date 2022-08-04	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$816.00 +200 vol $4.08 each	87,348
Filed 2022-08-08 09:49 Tx date 2022-08-05	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$607.50 +150 vol $4.05 each	87,698
Filed 2022-08-08 09:49 Tx date 2022-08-05	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$403.23 +100 vol $4.03 each	87,548
Filed 2022-08-08 09:48 Tx date 2022-08-05	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$402.50 +100 vol $4.03 each	87,448
Filed 2022-08-04 11:40 Tx date 2022-08-03	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,604 +400 vol $4.01 each	87,148
Filed 2022-08-04 11:39 Tx date 2022-08-03	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$796.00 +200 vol $3.98 each	86,748
Filed 2022-08-04 11:39 Tx date 2022-08-03	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,009 +500 vol $4.02 each	86,548
Filed 2022-08-04 11:38 Tx date 2022-08-02	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,660 +400 vol $4.15 each	86,048
Filed 2022-08-04 11:37 Tx date 2022-08-02	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,269 +300 vol $4.23 each	85,648
Filed 2022-08-04 11:36 Tx date 2022-08-02	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,275 +300 vol $4.25 each	85,348
Filed 2022-08-04 11:35 Tx date 2022-08-02	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$425.00 +100 vol $4.25 each	85,048
Filed 2022-08-04 11:35 Tx date 2022-08-01	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$8.98 +2 vol $4.49 each	84,948
Filed 2022-08-04 11:34 Tx date 2022-08-01	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$360.80 +88 vol $4.10 each	84,946
Filed 2022-08-01 14:36 Tx date 2022-08-01	$IPA ImmunoPrecise Antibodies Ltd.	Roodink, Ilse 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$433.00 +100 vol $4.33 each	3,342
Filed 2022-08-01 14:36 Tx date 2022-08-01	$IPA ImmunoPrecise Antibodies Ltd.	Roodink, Ilse 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$385.84 +91 vol $4.24 each	3,242
Filed 2022-08-01 14:35 Tx date 2022-08-01	$IPA ImmunoPrecise Antibodies Ltd.	Roodink, Ilse 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$65.10 +15 vol $4.34 each	3,151
Filed 2022-08-01 14:34 Tx date 2022-08-01	$IPA ImmunoPrecise Antibodies Ltd.	Roodink, Ilse 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$391.98 +94 vol $4.17 each	3,136
Filed 2022-08-01 14:34 Tx date 2022-08-01	$IPA ImmunoPrecise Antibodies Ltd.	Roodink, Ilse 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$8,480 +2,000 vol $4.24 each	3,042
Filed 2022-08-01 14:33 Tx date 2022-08-01	$IPA ImmunoPrecise Antibodies Ltd.	Roodink, Ilse 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$434.00 +100 vol $4.34 each	1,042
Filed 2022-06-09 15:41 Tx date 2022-06-09	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Convertible Debentures 36 - Conversion or exchange	-$35,000 vol	$0
Filed 2022-06-09 15:23 Tx date 2022-06-09	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 36 - Conversion or exchange	$174,998 +41,176 vol $4.25 each	84,858
Filed 2022-06-09 15:00 Tx date 2022-06-09	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 36 - Conversion or exchange	$174,998 +41,176 vol $4.25 each
Filed 2022-05-25 13:58 Tx date 2022-05-25	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Convertible Debentures 36 - Conversion or exchange	-$50,000 vol	$0
Filed 2022-05-25 13:56 Tx date 2022-05-25	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 36 - Conversion or exchange	$49,997 +11,764 vol $4.25 each	22,209
Filed 2022-05-12 16:50 Tx date 2022-05-12	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$5,400 +900 vol $6.00 each	53,870
Filed 2022-05-12 16:49 Tx date 2022-05-12	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$5,436 +900 vol $6.04 each	52,970
Filed 2022-05-12 16:47 Tx date 2022-05-12	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$1,210 +200 vol $6.05 each	52,070
Filed 2022-05-12 16:44 Tx date 2022-05-12	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$8,550 +1,500 vol $5.70 each	51,870
Filed 2022-05-12 16:44 Tx date 2022-05-12	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$569.00 +100 vol $5.69 each	50,370
Filed 2022-05-12 16:42 Tx date 2022-05-12	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$7,952 +1,400 vol $5.68 each	50,270
Filed 2022-05-12 09:26 Tx date 2022-05-11	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$221.50 +50 vol $4.43 each	43,682
Filed 2022-05-11 09:27 Tx date 2022-05-09	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$466.50 +100 vol $4.67 each	43,632
Filed 2022-05-11 09:26 Tx date 2022-05-09	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,820 +600 vol $4.70 each	43,532
Filed 2022-05-11 09:26 Tx date 2022-05-09	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$958.00 +200 vol $4.79 each	42,932
Filed 2022-05-11 09:25 Tx date 2022-05-09	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$479.00 +100 vol $4.79 each	42,732
Filed 2022-05-11 09:24 Tx date 2022-05-09	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4.80 +1 vol $4.80 each	42,632
Filed 2022-05-11 09:24 Tx date 2022-05-09	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,435 +299 vol $4.80 each	42,631
Filed 2022-05-09 10:28 Tx date 2022-05-05	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$542.00 +100 vol $5.42 each	42,332
Filed 2022-05-09 10:27 Tx date 2022-05-05	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$352.79 +63 vol $5.60 each	42,232
Filed 2022-05-09 10:26 Tx date 2022-05-05	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$336.00 +60 vol $5.60 each	42,169
Filed 2022-05-09 10:25 Tx date 2022-05-05	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$332.10 +60 vol $5.54 each	42,109
Filed 2022-05-09 10:22 Tx date 2022-05-04	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$507.85 +90 vol $5.64 each	42,049
Filed 2022-05-03 11:47 Tx date 2022-04-28	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$418.52 +75 vol $5.58 each	41,659
Filed 2022-05-03 11:45 Tx date 2022-04-29	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$556.96 +100 vol $5.57 each	41,959
Filed 2022-05-03 11:44 Tx date 2022-04-29	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$554.33 +100 vol $5.54 each	41,859
Filed 2022-05-03 11:43 Tx date 2022-04-29	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$553.00 +100 vol $5.53 each	41,759
Filed 2022-05-03 11:42 Tx date 2022-04-29	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$418.52 +75 vol $5.58 each
Filed 2022-04-27 23:01 Tx date 2022-04-27	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,395 +250 vol $5.58 each	41,584
Filed 2022-04-25 10:34 Tx date 2022-04-22	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,855 +500 vol $5.71 each	41,334
Filed 2022-04-25 10:34 Tx date 2022-04-22	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$565.00 +100 vol $5.65 each	40,834
Filed 2022-04-25 10:33 Tx date 2022-04-22	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$750.10 +130 vol $5.77 each	40,734
Filed 2022-04-25 10:33 Tx date 2022-04-22	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$572.00 +100 vol $5.72 each	40,604
Filed 2022-04-18 11:07 Tx date 2022-04-13	$IPA ImmunoPrecise Antibodies Ltd.	Van Hyfte, Dirk Medard Helena 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Charmquark EEN (Indirect Ownership)	Common Shares 22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition	$8,553,850 +1,565,865 vol $5.46 each	1,565,865
Filed 2022-04-18 11:06 Tx date 2022-04-13	$IPA ImmunoPrecise Antibodies Ltd.	Van Hyfte, Dirk Medard Helena 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Charmquark EEN (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2022-04-18 11:05 Tx date 2022-04-13	$IPA ImmunoPrecise Antibodies Ltd.	Brands, Ingrid Maria Henri 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Charmquark TWEE (Indirect Ownership)	Common Shares 22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition	$8,553,850 +1,565,865 vol $5.46 each	1,565,865
Filed 2022-04-18 10:59 Tx date 2022-04-13	$IPA ImmunoPrecise Antibodies Ltd.	Brands, Ingrid Maria Henri 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Charmquark TWEE (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2022-04-14 16:19 Tx date 2022-04-12	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,689 +300 vol $5.63 each	40,504
Filed 2022-04-14 16:18 Tx date 2022-04-12	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$570.00 +100 vol $5.70 each	40,204
Filed 2022-04-14 16:18 Tx date 2022-04-12	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,740 +300 vol $5.80 each	40,104
Filed 2022-04-14 16:18 Tx date 2022-04-12	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$583.36 +100 vol $5.83 each	39,804
Filed 2022-04-14 16:15 Tx date 2022-04-14	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$36,250 +5,000 vol $7.25 each	48,870
Filed 2022-04-13 14:51 Tx date 2022-04-11	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,767 +300 vol $5.89 each	39,704
Filed 2022-04-11 14:59 Tx date 2022-04-11	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,758 +300 vol $5.86 each	39,404
Filed 2022-04-11 14:58 Tx date 2022-04-11	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,152 +200 vol $5.76 each	39,104
Filed 2022-04-11 14:58 Tx date 2022-04-11	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$3,461 +600 vol $5.77 each	38,904
Filed 2022-04-11 14:53 Tx date 2022-04-11	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$53,290 +7,300 vol $7.30 each	43,870
Filed 2022-04-11 14:53 Tx date 2022-04-11	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$18,954 +2,700 vol $7.02 each	36,570
Filed 2022-04-11 12:01 Tx date 2022-04-11	$IPA ImmunoPrecise Antibodies Ltd.	Roodink, Ilse 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$5,388 +942 vol $5.72 each	942
Filed 2022-04-11 12:00 Tx date 2021-06-02	$IPA ImmunoPrecise Antibodies Ltd.	Roodink, Ilse 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2022-04-10 01:32 Tx date 2022-04-06	$IPA ImmunoPrecise Antibodies Ltd.	Dahl, Carla Cherry 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$59,900 +10,000 vol $5.99 each	10,000
Filed 2022-04-10 01:31 Tx date 2021-08-02	$IPA ImmunoPrecise Antibodies Ltd.	Dahl, Carla Cherry 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2022-04-08 09:29 Tx date 2022-04-07	$IPA ImmunoPrecise Antibodies Ltd.	Duplantis, Barry Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$695.00 +100 vol $6.95 each	1,200
Filed 2022-04-08 09:29 Tx date 2022-04-07	$IPA ImmunoPrecise Antibodies Ltd.	Duplantis, Barry Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,200 +600 vol $7.00 each	1,100
Filed 2022-04-06 21:45 Tx date 2022-04-06	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,207 +390 vol $5.66 each	38,304
Filed 2022-04-06 21:45 Tx date 2022-04-06	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,825 +500 vol $5.65 each	37,914
Filed 2022-04-06 21:44 Tx date 2022-04-06	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$575.00 +100 vol $5.75 each	37,414
Filed 2022-04-06 21:44 Tx date 2022-04-06	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,722 +300 vol $5.74 each	37,314
Filed 2022-04-05 12:57 Tx date 2022-04-05	$IPA ImmunoPrecise Antibodies Ltd.	Smith, Gregory Stuart 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$22,470 +3,000 vol $7.49 each	34,000
Filed 2022-04-05 02:07 Tx date 2022-04-04	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 5 - Senior Officer of Issuer Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$6,363 +900 vol $7.07 each	33,870
Filed 2022-04-05 02:06 Tx date 2022-04-04	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 5 - Senior Officer of Issuer Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$60,200 +8,600 vol $7.00 each	32,970
Filed 2022-04-05 02:06 Tx date 2022-04-04	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 5 - Senior Officer of Issuer Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$2,796 +400 vol $6.99 each	24,370
Filed 2022-04-03 19:40 Tx date 2022-04-01	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$674.70 +130 vol $5.19 each	37,014
Filed 2022-04-03 19:40 Tx date 2022-04-01	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,545 +300 vol $5.15 each	36,884
Filed 2022-04-03 19:39 Tx date 2022-04-01	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$505.00 +100 vol $5.05 each	36,584
Filed 2022-04-01 14:57 Tx date 2022-03-31	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,491 +300 vol $4.97 each	36,484
Filed 2022-04-01 14:57 Tx date 2022-03-31	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$504.00 +100 vol $5.04 each	36,184
Filed 2022-04-01 14:56 Tx date 2022-03-31	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$514.00 +100 vol $5.14 each	36,084
Filed 2022-04-01 12:42 Tx date 2022-04-01	$IPA ImmunoPrecise Antibodies Ltd.	McConn, Brad 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,232 +800 vol $5.29 each	4,000
Filed 2022-04-01 12:41 Tx date 2022-04-01	$IPA ImmunoPrecise Antibodies Ltd.	McConn, Brad 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,056 +200 vol $5.28 each	3,200
Filed 2022-03-31 11:55 Tx date 2022-03-30	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,497 +300 vol $4.99 each	35,984
Filed 2022-03-31 11:55 Tx date 2022-03-30	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$492.00 +100 vol $4.92 each	35,684
Filed 2022-03-31 11:54 Tx date 2022-03-30	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$6,318 +1,300 vol $4.86 each	35,584
Filed 2022-03-31 11:54 Tx date 2022-03-30	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,910 +600 vol $4.85 each	34,284
Filed 2022-03-31 11:53 Tx date 2022-03-30	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$6,006 +1,300 vol $4.62 each	33,684
Filed 2022-03-31 10:11 Tx date 2022-03-31	$IPA ImmunoPrecise Antibodies Ltd.	McConn, Brad 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$14,970 +3,000 vol $4.99 each	3,000
Filed 2022-03-31 10:10 Tx date 2022-01-08	$IPA ImmunoPrecise Antibodies Ltd.	McConn, Brad 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2022-03-30 17:29 Tx date 2022-03-30	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 5 - Senior Officer of Issuer Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$14,898 +2,600 vol $5.73 each	23,970
Filed 2022-03-30 17:28 Tx date 2022-03-30	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 5 - Senior Officer of Issuer Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$4,018 +700 vol $5.74 each	21,370
Filed 2022-03-30 17:28 Tx date 2022-03-30	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 5 - Senior Officer of Issuer Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$28,750 +5,000 vol $5.75 each	20,670
Filed 2022-03-30 17:27 Tx date 2022-03-30	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 5 - Senior Officer of Issuer Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$7,223 +1,200 vol $6.02 each	15,670
Filed 2022-03-30 17:26 Tx date 2022-03-30	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 5 - Senior Officer of Issuer Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$3,100 +500 vol $6.20 each	14,470
Filed 2022-03-30 17:22 Tx date 2022-03-30	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 5 - Senior Officer of Issuer Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$14,898 +2,600 vol $5.73 each
Filed 2022-03-30 17:22 Tx date 2022-03-30	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 5 - Senior Officer of Issuer Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$4,018 +700 vol $5.74 each
Filed 2022-03-30 17:22 Tx date 2022-03-30	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 5 - Senior Officer of Issuer Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$28,750 +5,000 vol $5.75 each
Filed 2022-03-30 17:21 Tx date 2022-03-30	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 5 - Senior Officer of Issuer Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$7,223 +1,200 vol $6.02 each
Filed 2022-03-30 17:20 Tx date 2022-03-30	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 5 - Senior Officer of Issuer Holder: Republique Capital (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$3,100 +500 vol $6.20 each
Filed 2022-02-17 16:07 Tx date 2022-02-16	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$16,064 +3,150 vol $5.10 each	32,384
Filed 2022-02-14 13:40 Tx date 2022-02-11	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,604 +300 vol $5.35 each	29,234
Filed 2022-02-14 13:39 Tx date 2022-02-11	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,582 +300 vol $5.28 each	28,934
Filed 2022-02-10 01:54 Tx date 2022-02-09	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,609 +300 vol $5.37 each	28,634
Filed 2022-02-10 01:53 Tx date 2022-02-09	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,508 +835 vol $5.40 each	28,334
Filed 2022-02-10 01:53 Tx date 2022-02-09	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,967 +365 vol $5.39 each	27,499
Filed 2022-02-10 01:43 Tx date 2022-02-09	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$18,495 +2,700 vol $6.85 each	10,445
Filed 2022-02-10 01:41 Tx date 2022-02-09	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,052 +300 vol $6.84 each	7,745
Filed 2022-01-17 18:46 Tx date 2022-01-08	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 5 - Senior Officer of Issuer Direct Ownership	Convertible Debentures 00 - Opening Balance-Initial SEDI Report		$50,000
Filed 2022-01-17 17:26 Tx date 2022-01-08	$IPA ImmunoPrecise Antibodies Ltd.	McConn, Brad 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 00 - Opening Balance-Initial SEDI Report		42,000
Filed 2022-01-17 17:15 Tx date 2022-01-08	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 00 - Opening Balance-Initial SEDI Report		40,000
Filed 2022-01-17 17:10 Tx date 2022-01-08	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 5 - Senior Officer of Issuer Holder: Republique Capital (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report		13,970
Filed 2022-01-17 17:09 Tx date 2022-01-08	$IPA ImmunoPrecise Antibodies Ltd.	Chabot, Frederic 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report		7,445
Filed 2022-01-17 10:00 Tx date 2022-01-13	$IPA ImmunoPrecise Antibodies Ltd.	Anderson-Helbling, Lisa 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$124,500 +15,000 vol $8.30 each	105,000
Filed 2022-01-13 12:36 Tx date 2022-01-08	$IPA ImmunoPrecise Antibodies Ltd.	Roodink, Ilse 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$397,000 +50,000 vol $7.94 each	65,000
Filed 2022-01-13 12:35 Tx date 2021-06-02	$IPA ImmunoPrecise Antibodies Ltd.	Roodink, Ilse 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 00 - Opening Balance-Initial SEDI Report		15,000
Filed 2022-01-12 00:42 Tx date 2022-01-08	$IPA ImmunoPrecise Antibodies Ltd.	Duplantis, Barry Neil 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$198,500 +25,000 vol $7.94 each	27,000
Filed 2022-01-12 00:35 Tx date 2022-01-08	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$952,800 +120,000 vol $7.94 each	540,000
Filed 2022-01-12 00:18 Tx date 2022-01-11	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$11,497 +1,900 vol $6.05 each	27,134
Filed 2021-12-31 17:21 Tx date 2021-12-30	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,647 +300 vol $5.49 each	25,234
Filed 2021-12-31 17:20 Tx date 2021-12-30	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,977 +900 vol $5.53 each	24,034
Filed 2021-12-31 17:19 Tx date 2021-12-30	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,959 +900 vol $5.51 each	24,934
Filed 2021-12-31 17:19 Tx date 2021-12-30	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,647 +300 vol $5.49 each
Filed 2021-12-31 17:16 Tx date 2021-12-30	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,647 +300 vol $5.49 each
Filed 2021-12-31 17:15 Tx date 2021-12-30	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,959 +900 vol $5.51 each
Filed 2021-12-31 17:15 Tx date 2021-12-30	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,977 +900 vol $5.53 each
Filed 2021-12-29 18:00 Tx date 2021-12-29	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$8,190 +1,500 vol $5.46 each	23,134
Filed 2021-12-29 18:00 Tx date 2021-12-29	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$3,249 +600 vol $5.42 each	21,634
Filed 2021-12-29 17:59 Tx date 2021-12-29	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,635 +300 vol $5.45 each	21,034
Filed 2021-12-29 17:57 Tx date 2021-12-29	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,629 +300 vol $5.43 each	20,734
Filed 2021-12-21 20:06 Tx date 2021-12-20	$IPA ImmunoPrecise Antibodies Ltd.	Smith, Gregory Stuart 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$30,000 +20,000 vol $1.50 each	31,000
Filed 2021-12-21 20:05 Tx date 2021-12-20	$IPA ImmunoPrecise Antibodies Ltd.	Smith, Gregory Stuart 4 - Director of Issuer Direct Ownership	Options Stock Options 51 - Exercise of options	$-30,000 -20,000 vol $1.50 each	45,000
Filed 2021-11-12 16:43 Tx date 2021-11-12	$IPA ImmunoPrecise Antibodies Ltd.	Kuo, James 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$37,500 +25,000 vol $1.50 each	25,000
Filed 2021-11-12 16:42 Tx date 2021-11-12	$IPA ImmunoPrecise Antibodies Ltd.	Kuo, James 4 - Director of Issuer Direct Ownership	Options Stock Options 51 - Exercise of options	$-37,500 -25,000 vol $1.50 each	35,000
Filed 2021-10-22 11:28 Tx date 2021-10-19	$IPA ImmunoPrecise Antibodies Ltd.	Burke, Robert 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	+20,000 vol	30,000
Filed 2021-10-22 11:27 Tx date 2021-10-19	$IPA ImmunoPrecise Antibodies Ltd.	Burke, Robert 4 - Director of Issuer Direct Ownership	Options Stock Options 51 - Exercise of options	-20,000 vol	45,000
Filed 2021-08-30 20:53 Tx date 2021-08-26	$IPA ImmunoPrecise Antibodies Ltd.	Smith, Gregory Stuart 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$8,758 +1,000 vol $8.76 each	11,000
Filed 2021-08-11 08:20 Tx date 2021-08-06	$IPA ImmunoPrecise Antibodies Ltd.	Dahl, Carla Cherry 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$413,550 +45,000 vol $9.19 each	45,000
Filed 2021-08-11 08:18 Tx date 2021-08-02	$IPA ImmunoPrecise Antibodies Ltd.	Dahl, Carla Cherry 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 00 - Opening Balance-Initial SEDI Report
Filed 2021-08-10 17:03 Tx date 2021-08-01	$IPA ImmunoPrecise Antibodies Ltd.	Duplantis, Barry Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report		500
Filed 2021-08-10 17:03 Tx date 2021-08-01	$IPA ImmunoPrecise Antibodies Ltd.	Duplantis, Barry Neil 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 00 - Opening Balance-Initial SEDI Report		2,000
Filed 2021-07-14 14:58 Tx date 2021-07-14	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$11,459 +2,000 vol $5.73 each	20,434
Filed 2021-07-12 11:20 Tx date 2021-07-12	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo 4 - Director of Issuer Holder: Patricia Finlayson (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$6,550 +1,000 vol $6.55 each	251,040
Filed 2021-07-09 15:35 Tx date 2021-07-09	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo 4 - Director of Issuer Holder: Patricia Finlayson (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$6,820 +1,000 vol $6.82 each	250,040
Filed 2021-06-09 10:51 Tx date 2021-06-09	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo 4 - Director of Issuer Holder: Patricia Finlayson (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$8,000 +1,000 vol $8.00 each	249,040
Filed 2021-05-18 23:09 Tx date 2021-05-18	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo 4 - Director of Issuer Holder: Patricia Finlayson (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$1,805 +200 vol $9.03 each	248,040
Filed 2021-05-13 15:30 Tx date 2021-05-13	$IPA ImmunoPrecise Antibodies Ltd.	Burke, Robert 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$19,000 +2,000 vol $9.50 each	10,000
Filed 2021-05-12 18:51 Tx date 2021-05-12	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$64,260 +9,000 vol $7.14 each	18,434
Filed 2021-03-16 11:30 Tx date 2021-03-16	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo 4 - Director of Issuer Holder: Patricia Finlayson (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$4,071 +300 vol $13.57 each	247,840
Filed 2021-03-11 15:45 Tx date 2021-03-11	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo 4 - Director of Issuer Holder: Patricia Finlayson (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$4,425 +300 vol $14.75 each	247,540
Filed 2021-01-25 09:48 Tx date 2020-11-23	$IPA ImmunoPrecise Antibodies Ltd.	Abdiche, Yasmina Noubia 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 37 - Stock split or consolidation	-200,000 vol	50,000
Filed 2021-01-25 08:14 Tx date 2020-04-01	$IPA ImmunoPrecise Antibodies Ltd.	Abdiche, Yasmina Noubia 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 00 - Opening Balance-Initial SEDI Report		250,000
Filed 2021-01-12 07:16 Tx date 2020-11-23	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo 4 - Director of Issuer Direct Ownership	Options Stock Options 37 - Stock split or consolidation	-120,000 vol	30,000
Filed 2021-01-12 07:15 Tx date 2020-11-23	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo 4 - Director of Issuer Holder: Patricia Finlayson (Indirect Ownership)	Convertible Debentures 37 - Stock split or consolidation	-$68,000 vol	$17,000
Filed 2021-01-12 07:14 Tx date 2020-11-23	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo 4 - Director of Issuer Direct Ownership	Convertible Debentures 37 - Stock split or consolidation	-$115,200 vol	$28,800
Filed 2021-01-12 07:13 Tx date 2020-11-23	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo 4 - Director of Issuer Holder: Patricia Finlayson (Indirect Ownership)	Common Shares 37 - Stock split or consolidation	-988,960 vol	247,240
Filed 2021-01-12 07:09 Tx date 2020-11-23	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo 4 - Director of Issuer Holder: Brisio Innovations Inc. (Control or Direction)	Common Shares 37 - Stock split or consolidation	-2,240,000 vol	560,000
Filed 2021-01-12 07:07 Tx date 2020-11-23	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo 4 - Director of Issuer Direct Ownership	Common Shares 37 - Stock split or consolidation	-1,717,440 vol	429,360
Filed 2021-01-08 11:02 Tx date 2021-01-06	$IPA ImmunoPrecise Antibodies Ltd.	Smith, Gregory Stuart 4 - Director of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	+5,000 vol	65,000
Filed 2021-01-08 11:01 Tx date 2021-01-06	$IPA ImmunoPrecise Antibodies Ltd.	Lundstrom, Brian 4 - Director of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	+5,000 vol	35,000
Filed 2021-01-08 11:00 Tx date 2021-01-06	$IPA ImmunoPrecise Antibodies Ltd.	Burke, Robert 4 - Director of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	+5,000 vol	65,000
Filed 2021-01-08 10:58 Tx date 2021-01-06	$IPA ImmunoPrecise Antibodies Ltd.	Kuo, James 4 - Director of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	+5,000 vol	60,000
Filed 2021-01-08 10:47 Tx date 2020-11-23	$IPA ImmunoPrecise Antibodies Ltd.	Smith, Gregory Stuart 4 - Director of Issuer Direct Ownership	Options Stock Options 37 - Stock split or consolidation	-240,000 vol	60,000
Filed 2021-01-08 10:46 Tx date 2020-11-23	$IPA ImmunoPrecise Antibodies Ltd.	Smith, Gregory Stuart 4 - Director of Issuer Holder: Kari Ridd (Control or Direction)	Common Shares 37 - Stock split or consolidation	-4,000 vol	1,000
Filed 2021-01-08 10:45 Tx date 2020-11-23	$IPA ImmunoPrecise Antibodies Ltd.	Smith, Gregory Stuart 4 - Director of Issuer Direct Ownership	Common Shares 37 - Stock split or consolidation	-40,000 vol	10,000
Filed 2021-01-08 10:40 Tx date 2020-11-23	$IPA ImmunoPrecise Antibodies Ltd.	Lundstrom, Brian 4 - Director of Issuer Direct Ownership	Options Stock Options 37 - Stock split or consolidation	-120,000 vol	30,000
Filed 2021-01-08 10:38 Tx date 2020-11-23	$IPA ImmunoPrecise Antibodies Ltd.	Lundstrom, Brian 4 - Director of Issuer Direct Ownership	Common Shares 37 - Stock split or consolidation	-55,200 vol	13,800
Filed 2021-01-08 10:35 Tx date 2020-11-23	$IPA ImmunoPrecise Antibodies Ltd.	Lang, Stefan 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 37 - Stock split or consolidation	-280,000 vol	70,000
Filed 2021-01-08 10:34 Tx date 2020-11-23	$IPA ImmunoPrecise Antibodies Ltd.	Lang, Stefan 5 - Senior Officer of Issuer Direct Ownership	Common Shares 37 - Stock split or consolidation	-8,000 vol	2,000
Filed 2021-01-08 10:31 Tx date 2020-11-23	$IPA ImmunoPrecise Antibodies Ltd.	Kuo, James 4 - Director of Issuer Direct Ownership	Options Stock Options 37 - Stock split or consolidation	-220,000 vol	55,000
Filed 2021-01-08 10:27 Tx date 2020-11-23	$IPA ImmunoPrecise Antibodies Ltd.	Burke, Robert 4 - Director of Issuer Direct Ownership	Options Stock Options 37 - Stock split or consolidation	-240,000 vol	60,000
Filed 2021-01-08 10:26 Tx date 2020-11-23	$IPA ImmunoPrecise Antibodies Ltd.	Burke, Robert 4 - Director of Issuer Holder: Elizabeth Grant (Control or Direction)	Common Shares 37 - Stock split or consolidation	-34,400 vol	8,600
Filed 2021-01-08 10:25 Tx date 2020-11-23	$IPA ImmunoPrecise Antibodies Ltd.	Burke, Robert 4 - Director of Issuer Direct Ownership	Common Shares 37 - Stock split or consolidation	-32,000 vol	8,000
Filed 2021-01-08 10:25 Tx date 2021-01-06	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$101,500 +5,000 vol $20.30 each	155,000
Filed 2021-01-08 10:23 Tx date 2020-11-23	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Convertible Debentures 37 - Stock split or consolidation	-$140,000 vol	$35,000
Filed 2021-01-08 10:22 Tx date 2020-11-23	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 37 - Stock split or consolidation	-1,680,000 vol	420,000
Filed 2021-01-08 10:21 Tx date 2020-11-23	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 37 - Stock split or consolidation	-37,735 vol	9,434
Filed 2021-01-08 10:19 Tx date 2020-11-23	$IPA ImmunoPrecise Antibodies Ltd.	Anderson-Helbling, Lisa 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 37 - Stock split or consolidation	-360,000 vol	90,000
Filed 2021-01-08 10:18 Tx date 2020-11-23	$IPA ImmunoPrecise Antibodies Ltd.	Anderson-Helbling, Lisa 5 - Senior Officer of Issuer Direct Ownership	Common Shares 37 - Stock split or consolidation	-8,000 vol	2,000
Filed 2020-10-28 12:42 Tx date 2020-10-28	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Holder: Patricia Finlayson (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$10,476 +5,400 vol $1.94 each	1,236,200
Filed 2020-10-22 18:00 Tx date 2020-10-22	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Holder: Patricia Finlayson (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$6,656 +3,200 vol $2.08 each	1,230,800
Filed 2020-09-25 08:32 Tx date 2020-09-23	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Holder: Brisio Innovations Inc. (Control or Direction)	Common Shares 54 - Exercise of warrants	$312,500 +250,000 vol $1.25 each	2,800,000
Filed 2020-09-25 08:27 Tx date 2020-09-23	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Holder: Brisio Innovations Inc. (Control or Direction)	Warrants 54 - Exercise of warrants	$-312,500 -250,000 vol $1.25 each	0
Filed 2020-09-18 17:39 Tx date 2020-09-16	$IPA ImmunoPrecise Antibodies Ltd.	Malberg, Miko 3 - 10% Security Holder of Issuer Holder: Kokkuhoideur OU (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-139,989.36 -72,100 vol $1.94 each	1,576,000
Filed 2020-09-18 17:38 Tx date 2020-09-15	$IPA ImmunoPrecise Antibodies Ltd.	Malberg, Miko 3 - 10% Security Holder of Issuer Holder: Kokkuhoideur OU (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-557,647.09 -271,150 vol $2.06 each	1,648,100
Filed 2020-09-18 17:36 Tx date 2020-09-14	$IPA ImmunoPrecise Antibodies Ltd.	Malberg, Miko 3 - 10% Security Holder of Issuer Holder: Kokkuhoideur OU (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-113,732.675 -56,750 vol $2.00 each	1,919,250
Filed 2020-09-18 17:34 Tx date 2020-09-16	$IPA ImmunoPrecise Antibodies Ltd.	Malberg, Miko 3 - 10% Security Holder of Issuer Holder: Topanga OU (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-139,989.36 -72,100 vol $1.94 each	932,000
Filed 2020-09-18 17:31 Tx date 2020-09-15	$IPA ImmunoPrecise Antibodies Ltd.	Malberg, Miko 3 - 10% Security Holder of Issuer Holder: Topanga OU (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-557,647.09 -271,150 vol $2.06 each	1,004,100
Filed 2020-09-18 17:27 Tx date 2020-09-14	$IPA ImmunoPrecise Antibodies Ltd.	Malberg, Miko 3 - 10% Security Holder of Issuer Holder: Topanga OU (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-113,732.675 -56,750 vol $2.00 each	1,275,250
Filed 2020-09-17 22:27 Tx date 2020-09-17	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Holder: Patricia Finlayson (Indirect Ownership)	Common Shares 54 - Exercise of warrants	$62,500 +50,000 vol $1.25 each	1,227,600
Filed 2020-09-17 22:25 Tx date 2020-09-17	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Holder: Patricia Finlayson (Indirect Ownership)	Warrants 54 - Exercise of warrants	$-62,500 -50,000 vol $1.25 each	0
Filed 2020-09-17 22:23 Tx date 2020-09-17	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Common Shares 54 - Exercise of warrants	$50,000 +40,000 vol $1.25 each	2,146,800
Filed 2020-09-17 22:20 Tx date 2020-09-17	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Warrants 54 - Exercise of warrants	$-50,000 -40,000 vol $1.25 each	0
Filed 2020-09-14 20:45 Tx date 2020-09-11	$IPA ImmunoPrecise Antibodies Ltd.	Malberg, Miko 3 - 10% Security Holder of Issuer Holder: Serenga OU (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-221,400.43 -116,834 vol $1.90 each	820,000
Filed 2020-09-14 20:45 Tx date 2020-09-10	$IPA ImmunoPrecise Antibodies Ltd.	Malberg, Miko 3 - 10% Security Holder of Issuer Holder: Serenga OU (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-470,683.227 -253,806 vol $1.85 each	936,834
Filed 2020-09-14 20:44 Tx date 2020-09-09	$IPA ImmunoPrecise Antibodies Ltd.	Malberg, Miko 3 - 10% Security Holder of Issuer Holder: Serenga OU (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-583,638.576 -309,360 vol $1.89 each	1,190,640
Filed 2020-09-14 20:36 Tx date 2020-09-11	$IPA ImmunoPrecise Antibodies Ltd.	Malberg, Miko 3 - 10% Security Holder of Issuer Holder: Kokkuhoideur OU (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-54,733.285 -28,883 vol $1.90 each	1,976,000
Filed 2020-09-14 20:35 Tx date 2020-09-10	$IPA ImmunoPrecise Antibodies Ltd.	Malberg, Miko 3 - 10% Security Holder of Issuer Holder: Kokkuhoideur OU (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-116,271.5865 -62,697 vol $1.85 each	2,004,883
Filed 2020-09-14 20:34 Tx date 2020-09-09	$IPA ImmunoPrecise Antibodies Ltd.	Malberg, Miko 3 - 10% Security Holder of Issuer Holder: Kokkuhoideur OU (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-144,173.972 -76,420 vol $1.89 each	2,067,580
Filed 2020-09-14 20:33 Tx date 2020-09-11	$IPA ImmunoPrecise Antibodies Ltd.	Malberg, Miko 3 - 10% Security Holder of Issuer Holder: Topanga OU (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-54,733.285 -28,883 vol $1.90 each	1,332,000
Filed 2020-09-14 20:33 Tx date 2020-09-10	$IPA ImmunoPrecise Antibodies Ltd.	Malberg, Miko 3 - 10% Security Holder of Issuer Holder: Topanga OU (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-116,271.5865 -62,697 vol $1.85 each	1,360,883
Filed 2020-09-14 20:32 Tx date 2020-09-09	$IPA ImmunoPrecise Antibodies Ltd.	Malberg, Miko 3 - 10% Security Holder of Issuer Holder: Topanga OU (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-144,173.972 -76,420 vol $1.89 each	1,423,580
Filed 2020-09-06 01:15 Tx date 2020-09-03	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Common Shares 54 - Exercise of warrants	$62,500 +50,000 vol $1.25 each	2,106,800
Filed 2020-09-06 01:11 Tx date 2020-09-03	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Warrants 54 - Exercise of warrants	$-62,500 -50,000 vol $1.25 each	40,000
Filed 2020-09-02 14:56 Tx date 2020-09-01	$IPA ImmunoPrecise Antibodies Ltd.	Lang, Stefan 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$170,000 +100,000 vol $1.70 each	350,000
Filed 2020-09-02 14:53 Tx date 2020-09-01	$IPA ImmunoPrecise Antibodies Ltd.	Anderson-Helbling, Lisa 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$255,000 +150,000 vol $1.70 each	450,000
Filed 2020-09-02 14:50 Tx date 2020-09-01	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$1,785,000 +1,050,000 vol $1.70 each	2,100,000
Filed 2020-08-24 19:32 Tx date 2020-08-17	$IPA ImmunoPrecise Antibodies Ltd.	Kuo, James 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-35,000 -25,000 vol $1.40 each	0
Filed 2020-08-20 12:19 Tx date 2020-08-17	$IPA ImmunoPrecise Antibodies Ltd.	Kuo, James 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$7,500 +25,000 vol $0.30 each	25,000
Filed 2020-08-20 12:18 Tx date 2020-08-17	$IPA ImmunoPrecise Antibodies Ltd.	Kuo, James 4 - Director of Issuer Direct Ownership	Options Stock Options 51 - Exercise of options	$-7,500 -25,000 vol $0.30 each	275,000
Filed 2020-08-19 18:57 Tx date 2016-12-29	$IPA ImmunoPrecise Antibodies Ltd.	Kuo, James 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2020-07-31 19:27 Tx date 2020-07-30	$IPA ImmunoPrecise Antibodies Ltd.	Lang, Stefan 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,230 +3,000 vol $1.41 each	10,000
Filed 2020-07-08 12:06 Tx date 2020-07-08	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$12,300 +10,000 vol $1.23 each	2,056,800
Filed 2020-06-19 14:17 Tx date 2020-06-18	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Common Shares 54 - Exercise of warrants	$295,000 +295,000 vol $1.00 each	2,046,800
Filed 2020-06-19 14:16 Tx date 2020-06-18	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Warrants 54 - Exercise of warrants	$-295,000 -295,000 vol $1.00 each	90,000
Filed 2020-06-17 12:50 Tx date 2020-06-16	$IPA ImmunoPrecise Antibodies Ltd.	Malberg, Miko 3 - 10% Security Holder of Issuer Holder: Kokkuhoideur OU (Indirect Ownership)	Common Shares 54 - Exercise of warrants	$62,500 +62,500 vol $1.00 each	2,144,000
Filed 2020-06-17 12:48 Tx date 2020-06-16	$IPA ImmunoPrecise Antibodies Ltd.	Malberg, Miko 3 - 10% Security Holder of Issuer Holder: Kokkuhoideur OU (Indirect Ownership)	Warrants 54 - Exercise of warrants	$-62,500 -62,500 vol $1.00 each	1,750,000
Filed 2020-05-20 17:52 Tx date 2020-05-15	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Convertible Debentures 16 - Acquisition or disposition under a prospectus exemption	$ +$175,000 vol $0.85 each	$175,000
Filed 2020-05-20 17:38 Tx date 2020-05-15	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Holder: Patricia Finlayson (Indirect Ownership)	Convertible Debentures 16 - Acquisition or disposition under a prospectus exemption	$ +$85,000 vol $0.85 each	$85,000
Filed 2020-05-20 17:34 Tx date 2020-05-15	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Convertible Debentures 16 - Acquisition or disposition under a prospectus exemption	$ +$144,000 vol $0.85 each	$144,000
Filed 2020-05-19 18:51 Tx date 2018-11-20	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Holder: Patricia Finlayson (Indirect Ownership)	Convertible Debentures 00 - Opening Balance-Initial SEDI Report
Filed 2020-05-19 18:47 Tx date 2018-11-20	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Convertible Debentures 00 - Opening Balance-Initial SEDI Report
Filed 2020-05-19 17:56 Tx date 2018-02-08	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Convertible Debentures 00 - Opening Balance-Initial SEDI Report
Filed 2020-05-13 10:49 Tx date 2020-05-13	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$7,200 +9,000 vol $0.80 each	1,751,800
Filed 2020-05-12 12:19 Tx date 2020-05-08	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,870 +3,500 vol $0.82 each	47,169
Filed 2020-05-12 12:18 Tx date 2020-05-08	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,640 +2,000 vol $0.82 each	43,669
Filed 2020-05-11 15:23 Tx date 2020-05-11	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$6,150 +7,500 vol $0.82 each	1,742,800
Filed 2020-05-11 15:23 Tx date 2020-05-11	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$800.00 +1,000 vol $0.80 each	1,735,300
Filed 2020-05-08 16:23 Tx date 2020-05-08	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,200 +1,500 vol $0.80 each	1,734,300
Filed 2020-05-06 12:08 Tx date 2020-05-06	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$3,900 +5,000 vol $0.78 each	1,732,800
Filed 2020-05-04 14:46 Tx date 2020-05-04	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$15,600 +20,000 vol $0.78 each	1,727,800
Filed 2020-04-29 15:24 Tx date 2020-04-29	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,940 +6,500 vol $0.76 each	1,707,800
Filed 2020-04-28 13:04 Tx date 2020-04-28	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Holder: Patricia Finlayson (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$3,080 +4,000 vol $0.77 each	1,177,600
Filed 2020-04-28 11:38 Tx date 2020-04-28	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Holder: Patricia Finlayson (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$3,950 +5,000 vol $0.79 each	1,173,600
Filed 2020-04-28 10:43 Tx date 2020-04-28	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$5,135 +6,500 vol $0.79 each	1,701,300
Filed 2020-04-09 17:47 Tx date 2018-04-16	$IPA ImmunoPrecise Antibodies Ltd.	Wheelock, Charles 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report		5,000
Filed 2020-04-09 17:39 Tx date 2018-04-16	$IPA ImmunoPrecise Antibodies Ltd.	Wheelock, Charles 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 00 - Opening Balance-Initial SEDI Report		200,000
Filed 2020-01-20 13:28 Tx date 2020-01-17	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$5,670 +9,000 vol $0.63 each	41,669
Filed 2020-01-16 21:49 Tx date 2020-01-16	$IPA ImmunoPrecise Antibodies Ltd.	Lundstrom, Brian 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$30,360 +69,000 vol $0.44 each	69,000
Filed 2020-01-16 21:47 Tx date 2019-10-03	$IPA ImmunoPrecise Antibodies Ltd.	Lundstrom, Brian 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2020-01-10 15:06 Tx date 2020-01-09	$IPA ImmunoPrecise Antibodies Ltd.	Burke, Robert 4 - Director of Issuer Holder: Elizabeth Grant (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$15,400 +28,000 vol $0.55 each	43,000
Filed 2020-01-10 15:05 Tx date 2020-01-09	$IPA ImmunoPrecise Antibodies Ltd.	Burke, Robert 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$13,750 +25,000 vol $0.55 each	40,000
Filed 2019-12-23 13:28 Tx date 2019-12-23	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Holder: Patricia Finlayson (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$4,770 +9,000 vol $0.53 each	1,168,600
Filed 2019-12-20 11:52 Tx date 2019-12-19	$IPA ImmunoPrecise Antibodies Ltd.	Anderson-Helbling, Lisa 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,055 +5,000 vol $0.411 each	10,000
Filed 2019-11-19 13:14 Tx date 2019-11-19	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Holder: Patricia Finlayson (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$5,900 +10,000 vol $0.59 each	1,159,600
Filed 2019-11-18 13:58 Tx date 2019-11-18	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$5,015 +8,500 vol $0.59 each	1,694,800
Filed 2019-11-15 14:40 Tx date 2019-11-14	$IPA ImmunoPrecise Antibodies Ltd.	Lang, Stefan 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,926 +7,000 vol $0.418 each	7,000
Filed 2019-11-15 14:36 Tx date 2019-10-01	$IPA ImmunoPrecise Antibodies Ltd.	Lang, Stefan 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2019-11-15 14:00 Tx date 2019-10-01	$IPA ImmunoPrecise Antibodies Ltd.	Lang, Stefan 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 00 - Opening Balance-Initial SEDI Report		250,000
Filed 2019-11-15 13:58 Tx date 2019-10-03	$IPA ImmunoPrecise Antibodies Ltd.	Lundstrom, Brian 4 - Director of Issuer Direct Ownership	Options Stock Options 00 - Opening Balance-Initial SEDI Report		150,000
Filed 2019-11-14 12:31 Tx date 2019-11-14	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$6,000 +10,000 vol $0.60 each	1,686,300
Filed 2019-11-13 14:51 Tx date 2019-11-13	$IPA ImmunoPrecise Antibodies Ltd.	Anderson-Helbling, Lisa 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,289 +5,000 vol $0.4579 each	5,000
Filed 2019-11-13 14:49 Tx date 2019-01-07	$IPA ImmunoPrecise Antibodies Ltd.	Anderson-Helbling, Lisa 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2019-11-13 12:24 Tx date 2019-11-13	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$6,000 +10,000 vol $0.60 each	1,676,300
Filed 2019-11-12 12:57 Tx date 2019-11-11	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$5,699 +10,000 vol $0.57 each	1,666,300
Filed 2019-11-07 17:04 Tx date 2019-11-07	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,275 +7,500 vol $0.57 each	1,656,300
Filed 2019-10-28 10:40 Tx date 2019-10-28	$IPA ImmunoPrecise Antibodies Ltd.	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,700 +5,000 vol $0.54 each	473,220
Filed 2019-10-16 12:38 Tx date 2019-10-16	$IPA ImmunoPrecise Antibodies Ltd.	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,500 +5,000 vol $0.50 each	468,220
Filed 2019-10-10 12:27 Tx date 2019-10-10	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$45,000 +100,000 vol $0.45 each	1,648,800
Filed 2019-10-09 14:36 Tx date 2019-10-09	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,650 +10,000 vol $0.465 each	1,548,800
Filed 2019-10-03 16:03 Tx date 2019-10-03	$IPA ImmunoPrecise Antibodies Ltd.	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$780.00 +1,500 vol $0.52 each	463,220
Filed 2019-10-03 16:03 Tx date 2019-10-03	$IPA ImmunoPrecise Antibodies Ltd.	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,785 +3,500 vol $0.51 each	461,720
Filed 2019-10-01 10:40 Tx date 2019-10-01	$IPA ImmunoPrecise Antibodies Ltd.	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,700 +10,000 vol $0.47 each	1,538,800
Filed 2019-09-20 03:36 Tx date 2019-09-19	$IPA ImmunoPrecise Antibodies Ltd.	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$3,000 +5,000 vol $0.60 each	458,220
Filed 2019-09-12 13:25 Tx date 2019-09-10	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$273.50 +475 vol $0.58 each	32,669
Filed 2019-09-12 13:24 Tx date 2019-09-10	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$863.70 +1,500 vol $0.58 each	32,194
Filed 2019-09-12 13:24 Tx date 2019-09-10	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$863.70 +1,500 vol $0.58 each	30,694
Filed 2019-09-12 13:23 Tx date 2019-09-10	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,015 +3,500 vol $0.58 each	29,194
Filed 2019-07-17 14:43 Tx date 2019-07-17	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$487.00 +1,000 vol $0.487 each	25,694
Filed 2019-07-17 14:42 Tx date 2019-07-17	$IPA ImmunoPrecise Antibodies Ltd.	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,013 +4,000 vol $0.50 each	24,694
Filed 2019-06-04 15:13 Tx date 2019-06-03	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,087 +4,000 vol $0.52 each	20,694
Filed 2019-05-30 14:00 Tx date 2019-05-30	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$6,899 +10,000 vol $0.69 each	1,528,800
Filed 2019-05-17 11:30 Tx date 2019-05-16	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Holder: Patricia Finlayson (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$4,830 +7,000 vol $0.69 each	1,149,600
Filed 2019-04-30 08:53 Tx date 2019-03-26	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-7,800 -10,000 vol $0.78 each	4,682,130
Filed 2019-04-30 08:53 Tx date 2019-03-26	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-23,655 -30,000 vol $0.79 each	4,692,130
Filed 2019-04-30 08:52 Tx date 2019-03-26	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-64,000 -80,000 vol $0.80 each	4,722,130
Filed 2019-04-30 08:52 Tx date 2019-03-26	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-16,150 -20,000 vol $0.81 each	4,802,130
Filed 2019-04-30 08:51 Tx date 2019-03-26	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-16,020 -20,000 vol $0.80 each	4,822,130
Filed 2019-04-30 08:51 Tx date 2019-03-26	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-16,200 -20,000 vol $0.81 each	4,842,130
Filed 2019-04-30 08:50 Tx date 2019-03-26	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-16,070 -20,000 vol $0.80 each	4,862,130
Filed 2019-04-30 08:50 Tx date 2019-03-26	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-78,000 -100,000 vol $0.78 each	4,882,130
Filed 2019-04-30 08:47 Tx date 2019-04-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-10,250 -12,500 vol $0.82 each	4,509,630
Filed 2019-04-30 08:46 Tx date 2019-04-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-10,660 -13,000 vol $0.82 each	4,522,130
Filed 2019-04-30 08:45 Tx date 2019-04-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-6,480 -8,000 vol $0.81 each	4,535,130
Filed 2019-04-30 08:45 Tx date 2019-04-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-8,200 -10,000 vol $0.82 each	4,543,130
Filed 2019-04-30 08:44 Tx date 2019-04-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-8,100 -10,000 vol $0.81 each	4,553,130
Filed 2019-04-30 08:44 Tx date 2019-04-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-3,360 -4,000 vol $0.84 each	4,563,130
Filed 2019-04-30 08:43 Tx date 2019-04-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-12,600 -15,000 vol $0.84 each	4,567,130
Filed 2019-04-30 08:42 Tx date 2019-04-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-8,250 -10,000 vol $0.82 each	4,582,130
Filed 2019-04-30 08:42 Tx date 2019-04-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-8,240 -10,000 vol $0.82 each	4,592,130
Filed 2019-04-30 08:41 Tx date 2019-04-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-8,360 -10,000 vol $0.84 each	4,602,130
Filed 2019-04-30 08:40 Tx date 2019-04-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-8,100 -10,000 vol $0.81 each	4,612,130
Filed 2019-04-30 08:39 Tx date 2019-04-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-8,000 -10,000 vol $0.80 each	4,622,130
Filed 2019-04-30 08:38 Tx date 2019-04-26	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-7,900 -10,000 vol $0.79 each	4,632,130
Filed 2019-04-30 08:37 Tx date 2019-04-26	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-7,800 -10,000 vol $0.78 each	4,642,130
Filed 2019-04-30 08:37 Tx date 2019-04-26	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-15,400 -20,000 vol $0.77 each	4,652,130
Filed 2019-04-30 08:35 Tx date 2019-04-26	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-8,000 -10,000 vol $0.80 each	4,672,130
Filed 2019-03-27 Tx date 2019-03-26	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,460 +2,000 vol $0.73 each	1,518,800
Filed 2019-03-12 Tx date 2019-03-12	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Holder: Patricia Finlayson (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$15,000 +20,000 vol $0.75 each	1,142,600
Filed 2019-03-12 Tx date 2019-03-12	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-750,000 -1,000,000 vol $0.75 each	4,982,130
Filed 2019-03-01 Tx date 2019-03-01	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-24,055.50 -32,074 vol $0.75 each	5,982,130
Filed 2019-02-22 Tx date 2019-02-21	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,534 +8,100 vol $0.56 each	16,694
Filed 2019-02-15 Tx date 2019-02-14	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Holder: Patricia Finlayson (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$915.00 +1,500 vol $0.61 each	1,119,100
Filed 2019-02-15 Tx date 2019-02-15	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Holder: Patricia Finlayson (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$2,135 +3,500 vol $0.61 each	1,122,600
Filed 2019-02-01 Tx date 2019-02-01	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Holder: Patricia Finlayson (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$2,415 +3,500 vol $0.69 each	1,117,600
Filed 2019-01-29 Tx date 2019-01-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Malberg, Miko 3 - 10% Security Holder of Issuer Holder: Serenga OU (Indirect Ownership)	Warrants 00 - Opening Balance-Initial SEDI Report		1,000,000
Filed 2019-01-29 Tx date 2019-01-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Malberg, Miko 3 - 10% Security Holder of Issuer Holder: Topanga OU (Indirect Ownership)	Warrants 00 - Opening Balance-Initial SEDI Report		250,000
Filed 2019-01-29 Tx date 2019-01-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Malberg, Miko 3 - 10% Security Holder of Issuer Direct Ownership	Warrants 00 - Opening Balance-Initial SEDI Report
Filed 2019-01-29 Tx date 2019-01-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Malberg, Miko 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2019-01-29 Tx date 2019-01-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Malberg, Miko 3 - 10% Security Holder of Issuer Holder: Autumn Spirit OU (Indirect Ownership)	Warrants 00 - Opening Balance-Initial SEDI Report		1,500,000
Filed 2019-01-29 Tx date 2019-01-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Malberg, Miko 3 - 10% Security Holder of Issuer Holder: Autumn Spirit OU (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report		750,000
Filed 2019-01-29 Tx date 2019-01-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Malberg, Miko 3 - 10% Security Holder of Issuer Holder: Topanga OU (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report		1,500,000
Filed 2019-01-29 Tx date 2019-01-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Malberg, Miko 3 - 10% Security Holder of Issuer Holder: Kokkuhoideur OU (Indirect Ownership)	Warrants 00 - Opening Balance-Initial SEDI Report		1,812,500
Filed 2019-01-29 Tx date 2019-01-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Malberg, Miko 3 - 10% Security Holder of Issuer Holder: Serenga OU (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report		1,500,000
Filed 2019-01-29 Tx date 2019-01-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Malberg, Miko 3 - 10% Security Holder of Issuer Holder: Kokkuhoideur OU (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report		2,081,500
Filed 2019-01-18 Tx date 2019-01-10	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,320 +4,000 vol $0.58 each	7,594
Filed 2019-01-18 Tx date 2019-01-10	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,084 +3,594 vol $0.58 each	3,594
Filed 2019-01-18 Tx date 2019-01-10	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$570.00 +1,000 vol $0.57 each	8,594
Filed 2019-01-15 Tx date 2019-01-14	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Orloske, Jason 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$100,000 +100,000 vol $1.00 each	100,000
Filed 2019-01-15 Tx date 2019-01-07	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Anderson-Helbling, Lisa 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 00 - Opening Balance-Initial SEDI Report
Filed 2019-01-15 Tx date 2019-01-14	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Anderson-Helbling, Lisa 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$300,000 +300,000 vol $1.00 each	300,000
Filed 2019-01-15 Tx date 2018-12-26	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Orloske, Jason 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 00 - Opening Balance-Initial SEDI Report
Filed 2019-01-10 Tx date 2019-01-09	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Burke, Robert 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$5,475 +7,500 vol $0.73 each	15,000
Filed 2019-01-10 Tx date 2017-12-18	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Burke, Robert 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2019-01-10 Tx date 2019-01-08	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Burke, Robert 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$5,475 +7,500 vol $0.73 each	7,500
Filed 2019-01-10 Tx date 2019-01-08	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Burke, Robert 4 - Director of Issuer Holder: Elizabeth Grant (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$10,950 +15,000 vol $0.73 each	15,000
Filed 2019-01-10 Tx date 2017-12-18	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Burke, Robert 4 - Director of Issuer Holder: Elizabeth Grant (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2019-01-03 Tx date 2017-12-18	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Burke, Robert 4 - Director of Issuer Direct Ownership	Options Stock Options 00 - Opening Balance-Initial SEDI Report
Filed 2019-01-03 Tx date 2017-12-18	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Burke, Robert 4 - Director of Issuer Direct Ownership	Options Stock Options 00 - Opening Balance-Initial SEDI Report		100,000
Filed 2019-01-03 Tx date 2018-12-31	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Burke, Robert 4 - Director of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$200,000 +200,000 vol $1.00 each	300,000
Filed 2019-01-02 Tx date 2018-12-31	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$150,000 +150,000 vol $1.00 each	150,000
Filed 2019-01-02 Tx date 2018-12-31	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Smith, Gregory Stuart 4 - Director of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$200,000 +200,000 vol $1.00 each	300,000
Filed 2019-01-02 Tx date 2018-12-31	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Kuo, James 4 - Director of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$150,000 +150,000 vol $1.00 each	300,000
Filed 2019-01-02 Tx date 2018-12-31	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Robert Patrick 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$200,000 +200,000 vol $1.00 each	450,000
Filed 2019-01-02 Tx date 2018-11-20	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Options Stock Options 00 - Opening Balance-Initial SEDI Report
Filed 2019-01-02 Tx date 2018-12-31	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$350,000 +350,000 vol $1.00 each	1,050,000
Filed 2018-12-08 Tx date 2018-12-07	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Holder: Patricia Finlayson (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$13,000 +20,000 vol $0.65 each	1,114,100
Filed 2018-11-29 Tx date 2018-11-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Holder: Patricia Finlayson (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$3,000 +4,000 vol $0.75 each	1,094,100
Filed 2018-11-28 Tx date 2018-11-28	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Holder: Patricia Finlayson (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$4,500 +6,000 vol $0.75 each	1,090,100
Filed 2018-11-22 Tx date 2018-11-20	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Warrants 00 - Opening Balance-Initial SEDI Report		385,000
Filed 2018-11-22 Tx date 2018-11-20	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Holder: Patricia Finlayson (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report		1,084,100
Filed 2018-11-22 Tx date 2018-11-20	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report		1,516,800
Filed 2018-11-22 Tx date 2018-11-20	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Holder: Brisio Innovations Inc. (Indirect Ownership)	Warrants 00 - Opening Balance-Initial SEDI Report		250,000
Filed 2018-11-22 Tx date 2018-11-20	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Holder: Brisio Innovations Inc. (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report		2,550,000
Filed 2018-11-22 Tx date 2018-11-20	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Andreola, Gianpaolo Fabrisio 4 - Director of Issuer Holder: Patricia Finlayson (Indirect Ownership)	Warrants 00 - Opening Balance-Initial SEDI Report		50,000
Filed 2018-11-13 Tx date 2018-11-09	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Robert Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-415,000 -500,000 vol $0.83 each	4,001,113
Filed 2018-11-06 Tx date 2018-10-31	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-1,680 -2,000 vol $0.84 each
Filed 2018-11-06 Tx date 2018-10-16	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-19,065 -20,500 vol $0.93 each	6,261,204
Filed 2018-11-06 Tx date 2018-10-16	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$19,065 +20,500 vol $0.93 each
Filed 2018-11-06 Tx date 2018-10-16	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-19,065 -20,500 vol $0.93 each
Filed 2018-11-06 Tx date 2018-10-31	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-1,680 -2,000 vol $0.84 each	6,259,204
Filed 2018-11-05 Tx date 2018-10-16	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-19,065 -20,500 vol $0.93 each	6,261,204
Filed 2018-11-05 Tx date 2018-10-31	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-1,680 -2,000 vol $0.84 each	6,259,204
Filed 2018-11-05 Tx date 2018-10-16	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$19,065 +20,500 vol $0.93 each
Filed 2018-11-02 Tx date 2018-11-02	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-198,450 -245,000 vol $0.81 each	6,036,704
Filed 2018-10-29 Tx date 2018-10-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Robert Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-5,197.50 -6,750 vol $0.77 each	4,501,113
Filed 2018-10-27 Tx date 2018-10-24	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-4,050 -5,000 vol $0.81 each	453,220
Filed 2018-10-23 Tx date 2018-10-22	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-4,350 -5,000 vol $0.87 each	463,220
Filed 2018-10-23 Tx date 2018-10-19	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-4,300 -5,000 vol $0.86 each	468,220
Filed 2018-10-23 Tx date 2018-10-23	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-4,250 -5,000 vol $0.85 each	458,220
Filed 2018-10-17 Tx date 2018-10-17	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Robert Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-690.00 -750 vol $0.92 each	4,507,863
Filed 2018-10-17 Tx date 2018-10-17	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Robert Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,395 -1,500 vol $0.93 each	4,508,613
Filed 2018-10-16 Tx date 2018-10-16	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Robert Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,250 -2,500 vol $0.90 each	4,510,113
Filed 2018-10-16 Tx date 2018-10-16	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Robert Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,740 -2,000 vol $0.87 each	4,512,613
Filed 2018-10-12 Tx date 2018-10-09	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-19,065 -20,500 vol $0.93 each	6,281,704
Filed 2018-10-11 Tx date 2018-10-09	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-46,000 -50,000 vol $0.92 each	6,302,204
Filed 2018-10-11 Tx date 2018-10-05	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-32,390 -39,500 vol $0.82 each	6,352,204
Filed 2018-10-11 Tx date 2018-10-05	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-22,550 -27,500 vol $0.82 each	6,402,204
Filed 2018-10-11 Tx date 2018-10-04	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-18,450 -22,500 vol $0.82 each	6,429,704
Filed 2018-10-11 Tx date 2018-10-03	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-5,160 -6,000 vol $0.86 each	6,452,204
Filed 2018-10-11 Tx date 2018-10-03	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-37,840 -44,000 vol $0.86 each	6,458,204
Filed 2018-10-11 Tx date 2018-10-05	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-8,610 -10,500 vol $0.82 each	6,391,704
Filed 2018-10-10 Tx date 2018-10-05	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-4,100 -5,000 vol $0.82 each	478,220
Filed 2018-10-10 Tx date 2018-10-09	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-4,550 -5,000 vol $0.91 each	473,220
Filed 2018-10-05 Tx date 2018-10-01	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-4,600 -5,000 vol $0.92 each	488,220
Filed 2018-10-05 Tx date 2018-10-04	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-4,150 -5,000 vol $0.83 each	483,220
Filed 2018-09-28 Tx date 2018-09-24	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Miss, Gabriele 3 - 10% Security Holder of Issuer Holder: Topanga OU (Control or Direction)	Common Shares 16 - Acquisition or disposition under a prospectus exemption	$250,000 +250,000 vol $1.00 each	1,500,000
Filed 2018-09-28 Tx date 2018-09-24	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Miss, Gabriele 3 - 10% Security Holder of Issuer Holder: Serenga OU (Control or Direction)	Warrants 00 - Opening Balance-Initial SEDI Report
Filed 2018-09-28 Tx date 2018-09-24	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Miss, Gabriele 3 - 10% Security Holder of Issuer Holder: Topanga OU (Control or Direction)	Warrants 16 - Acquisition or disposition under a prospectus exemption	$312,500 +250,000 vol $1.25 each	250,000
Filed 2018-09-28 Tx date 2018-09-24	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Miss, Gabriele 3 - 10% Security Holder of Issuer Holder: Serenga OU (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report		500,000
Filed 2018-09-28 Tx date 2018-09-24	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Miss, Gabriele 3 - 10% Security Holder of Issuer Holder: Kokkuhoideur OU (Control or Direction)	Warrants 00 - Opening Balance-Initial SEDI Report		1,562,500
Filed 2018-09-28 Tx date 2018-09-24	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Miss, Gabriele 3 - 10% Security Holder of Issuer Holder: Autumn Spirit OU (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report		750,000
Filed 2018-09-28 Tx date 2018-09-24	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Miss, Gabriele 3 - 10% Security Holder of Issuer Holder: Topanga OU (Control or Direction)	Warrants 00 - Opening Balance-Initial SEDI Report
Filed 2018-09-28 Tx date 2018-09-24	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Miss, Gabriele 3 - 10% Security Holder of Issuer Holder: Serenga OU (Control or Direction)	Warrants 16 - Acquisition or disposition under a prospectus exemption	$1,250,000 +1,000,000 vol $1.25 each	1,000,000
Filed 2018-09-28 Tx date 2018-09-24	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Miss, Gabriele 3 - 10% Security Holder of Issuer Holder: Serenga OU (Control or Direction)	Common Shares 16 - Acquisition or disposition under a prospectus exemption	$1,000,000 +1,000,000 vol $1.00 each	1,500,000
Filed 2018-09-28 Tx date 2018-09-24	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Miss, Gabriele 3 - 10% Security Holder of Issuer Holder: Topanga OU (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report		1,250,000
Filed 2018-09-28 Tx date 2018-09-24	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Miss, Gabriele 3 - 10% Security Holder of Issuer Holder: Autumn Spirit OU (Control or Direction)	Warrants 00 - Opening Balance-Initial SEDI Report		1,500,000
Filed 2018-09-28 Tx date 2018-09-24	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Miss, Gabriele 3 - 10% Security Holder of Issuer Holder: Kokkuhoideur OU (Control or Direction)	Warrants 16 - Acquisition or disposition under a prospectus exemption	$312,500 +250,000 vol $1.25 each	1,812,500
Filed 2018-09-28 Tx date 2018-09-24	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Miss, Gabriele 3 - 10% Security Holder of Issuer Holder: Serenga OU (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2018-09-28 Tx date 2018-09-24	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Miss, Gabriele 3 - 10% Security Holder of Issuer Holder: Serenga OU (Control or Direction)	Warrants 00 - Opening Balance-Initial SEDI Report
Filed 2018-09-28 Tx date 2018-09-24	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Miss, Gabriele 3 - 10% Security Holder of Issuer Holder: Kokkuhoideur OU (Control or Direction)	Common Shares 16 - Acquisition or disposition under a prospectus exemption	$250,000 +250,000 vol $1.00 each	2,081,500
Filed 2018-09-28 Tx date 2018-09-24	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Miss, Gabriele 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report		225,000
Filed 2018-09-28 Tx date 2018-09-24	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Miss, Gabriele 3 - 10% Security Holder of Issuer Holder: Kokkuhoideur OU (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report		1,831,500
Filed 2018-08-30 Tx date 2018-08-28	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-43,560 -44,000 vol $0.99 each	6,502,204
Filed 2018-08-30 Tx date 2018-08-24	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-24,849 -25,100 vol $0.99 each	6,555,204
Filed 2018-08-30 Tx date 2018-08-27	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-8,910 -9,000 vol $0.99 each	6,546,204
Filed 2018-08-30 Tx date 2018-08-23	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-9,900 -9,900 vol $1.00 each	6,580,304
Filed 2018-08-28 Tx date 2018-08-22	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2018-08-28 Tx date 2018-04-06	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2018-08-28 Tx date 2018-08-22	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-10,500.85 -10,195 vol $1.03 each
Filed 2018-08-28 Tx date 2018-08-22	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2018-08-28 Tx date 2018-08-24	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report		6,590,204
Filed 2018-08-28 Tx date 2018-08-22	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Raats, Jozef Maria Hendrik 3 - 10% Security Holder of Issuer Holder: Immusys BV (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-10,500.85 -10,195 vol $1.03 each
Filed 2018-08-13 Tx date 2018-08-13	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Robert Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,819 -1,700 vol $1.07 each	4,514,613
Filed 2018-08-10 Tx date 2018-08-10	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Robert Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,391 -1,300 vol $1.07 each	4,516,313
Filed 2018-08-10 Tx date 2018-08-10	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Robert Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-3,150 -3,000 vol $1.05 each	4,517,613
Filed 2018-08-09 Tx date 2018-08-09	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Robert Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-3,210 -3,000 vol $1.07 each	4,520,613
Filed 2018-08-01 Tx date 2018-08-01	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Robert Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-3,270 -3,000 vol $1.09 each	4,523,613
Filed 2018-07-18 Tx date 2018-07-18	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Robert Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-3,270 -3,000 vol $1.09 each	4,529,613
Filed 2018-07-18 Tx date 2018-07-18	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Robert Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-3,330 -3,000 vol $1.11 each	4,526,613
Filed 2018-07-12 Tx date 2018-07-11	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-5,250 -5,000 vol $1.05 each	498,220
Filed 2018-07-12 Tx date 2018-07-09	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-5,550 -5,000 vol $1.11 each	513,220
Filed 2018-07-12 Tx date 2018-07-12	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Robert Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-3,450 -3,000 vol $1.15 each	4,532,613
Filed 2018-07-12 Tx date 2018-07-11	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-5,100 -5,000 vol $1.02 each	503,220
Filed 2018-07-12 Tx date 2018-07-10	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-5,265 -5,000 vol $1.05 each	508,220
Filed 2018-07-12 Tx date 2018-07-12	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-5,650 -5,000 vol $1.13 each	493,220
Filed 2018-07-11 Tx date 2018-07-10	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-104,218 -97,400 vol $1.07 each	788,200
Filed 2018-07-11 Tx date 2018-07-10	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,199 -1,100 vol $1.09 each	889,900
Filed 2018-07-11 Tx date 2018-07-10	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-16,200 -15,000 vol $1.08 each	891,000
Filed 2018-07-11 Tx date 2018-07-10	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-4,558 -4,300 vol $1.06 each	885,600
Filed 2018-07-10 Tx date 2018-07-04	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-10,622 -9,400 vol $1.13 each	927,000
Filed 2018-07-10 Tx date 2018-07-03	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-117.00 -100 vol $1.17 each	946,900
Filed 2018-07-10 Tx date 2018-07-03	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-464.00 -400 vol $1.16 each	946,500
Filed 2018-07-10 Tx date 2018-07-03	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-11,020 -9,500 vol $1.16 each	937,000
Filed 2018-07-10 Tx date 2018-07-04	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-114.00 -100 vol $1.14 each	936,900
Filed 2018-07-10 Tx date 2018-07-04	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-565.00 -500 vol $1.13 each	936,400
Filed 2018-07-10 Tx date 2018-07-05	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-7,910 -7,000 vol $1.13 each	920,000
Filed 2018-07-10 Tx date 2018-07-05	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,280 -2,000 vol $1.14 each	918,000
Filed 2018-07-10 Tx date 2018-07-05	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,130 -1,000 vol $1.13 each	917,000
Filed 2018-07-10 Tx date 2018-07-06	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-12,320 -11,000 vol $1.12 each	906,000
Filed 2018-07-07 Tx date 2018-07-05	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-5,650 -5,000 vol $1.13 each	523,220
Filed 2018-07-07 Tx date 2018-07-03	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-5,750 -5,000 vol $1.15 each	538,220
Filed 2018-07-07 Tx date 2018-07-04	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-5,700 -5,000 vol $1.14 each	533,220
Filed 2018-07-07 Tx date 2018-07-05	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-5,750 -5,000 vol $1.15 each	528,220
Filed 2018-07-07 Tx date 2018-07-06	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-5,500 -5,000 vol $1.10 each	518,220
Filed 2018-07-03 Tx date 2018-06-22	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-4,320 -4,000 vol $1.08 each	983,000
Filed 2018-07-03 Tx date 2018-06-27	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-11,800 -10,000 vol $1.18 each	947,000
Filed 2018-07-03 Tx date 2018-06-26	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-11,300 -10,000 vol $1.13 each	957,000
Filed 2018-07-03 Tx date 2018-06-25	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-10,800 -10,000 vol $1.08 each	967,000
Filed 2018-07-03 Tx date 2018-06-22	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-6,420 -6,000 vol $1.07 each	977,000
Filed 2018-06-29 Tx date 2018-06-27	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-560.00 -500 vol $1.12 each	558,220
Filed 2018-06-29 Tx date 2018-06-27	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-6,100 -5,000 vol $1.22 each	553,220
Filed 2018-06-29 Tx date 2018-06-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-11,600 -10,000 vol $1.16 each	543,220
Filed 2018-06-29 Tx date 2018-06-25	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,800 -2,500 vol $1.12 each	570,720
Filed 2018-06-29 Tx date 2018-06-26	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-5,400 -5,000 vol $1.08 each	563,220
Filed 2018-06-29 Tx date 2018-06-25	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,775 -2,500 vol $1.11 each	568,220
Filed 2018-06-29 Tx date 2018-06-27	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-4,995 -4,500 vol $1.11 each	558,720
Filed 2018-06-25 Tx date 2018-06-21	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-5,217 -4,700 vol $1.11 each	987,000
Filed 2018-06-25 Tx date 2018-06-21	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,792 -1,600 vol $1.12 each	991,700
Filed 2018-06-25 Tx date 2018-06-21	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-112.00 -100 vol $1.12 each	993,300
Filed 2018-06-25 Tx date 2018-06-21	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-3,360 -3,000 vol $1.12 each	993,400
Filed 2018-06-25 Tx date 2018-06-21	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-678.00 -600 vol $1.13 each	996,400
Filed 2018-06-25 Tx date 2018-06-20	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-11,500 -10,000 vol $1.15 each	997,000
Filed 2018-06-25 Tx date 2018-06-19	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-944.00 -800 vol $1.18 each	1,007,000
Filed 2018-06-25 Tx date 2018-06-19	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-6,490 -5,500 vol $1.18 each	1,007,800
Filed 2018-06-25 Tx date 2018-06-19	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-4,366 -3,700 vol $1.18 each	1,013,300
Filed 2018-06-25 Tx date 2018-06-18	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-240.00 -200 vol $1.20 each	1,017,000
Filed 2018-06-25 Tx date 2018-06-12	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-3,472 -2,800 vol $1.24 each	1,017,200
Filed 2018-06-25 Tx date 2018-06-12	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,125 -900 vol $1.25 each	1,020,000
Filed 2018-06-25 Tx date 2018-06-12	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,250 -1,000 vol $1.25 each	1,020,900
Filed 2018-06-25 Tx date 2018-06-12	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-3,720 -3,000 vol $1.24 each	1,021,900
Filed 2018-06-25 Tx date 2018-06-12	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,875 -2,300 vol $1.25 each	1,024,900
Filed 2018-06-23 Tx date 2018-06-21	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-5,550 -5,000 vol $1.11 each	578,220
Filed 2018-06-23 Tx date 2018-06-20	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-5,750 -5,000 vol $1.15 each	583,220
Filed 2018-06-23 Tx date 2018-06-19	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,150 -1,000 vol $1.15 each	588,220
Filed 2018-06-23 Tx date 2018-06-19	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-4,640 -4,000 vol $1.16 each	589,220
Filed 2018-06-23 Tx date 2018-06-19	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-5,800 -5,000 vol $1.16 each	593,220
Filed 2018-06-23 Tx date 2018-06-22	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-5,550 -5,000 vol $1.11 each	573,220
Filed 2018-06-16 Tx date 2018-06-15	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-5,950 -5,000 vol $1.19 each	603,220
Filed 2018-06-16 Tx date 2018-06-14	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-6,000 -5,000 vol $1.20 each	608,220
Filed 2018-06-16 Tx date 2018-06-13	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-6,350 -5,000 vol $1.27 each	613,220
Filed 2018-06-16 Tx date 2018-06-12	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-6,400 -5,000 vol $1.28 each	618,220
Filed 2018-06-16 Tx date 2018-06-12	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-6,350 -5,000 vol $1.27 each	623,220
Filed 2018-06-16 Tx date 2018-06-15	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-5,950 -5,000 vol $1.19 each	598,220
Filed 2018-06-13 Tx date 2018-06-06	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-8,632 -8,300 vol $1.04 each	1,094,900
Filed 2018-06-13 Tx date 2018-06-04	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,461 -2,300 vol $1.07 each	1,105,900
Filed 2018-06-13 Tx date 2018-06-04	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,916 -2,700 vol $1.08 each	1,103,200
Filed 2018-06-13 Tx date 2018-06-11	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-120.00 -100 vol $1.20 each	1,027,200
Filed 2018-06-13 Tx date 2018-06-11	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,520 -2,100 vol $1.20 each	1,027,300
Filed 2018-06-13 Tx date 2018-06-11	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-4,114 -3,400 vol $1.21 each	1,029,400
Filed 2018-06-13 Tx date 2018-06-11	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-600.00 -500 vol $1.20 each	1,032,800
Filed 2018-06-13 Tx date 2018-06-11	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,178 -1,800 vol $1.21 each	1,033,300
Filed 2018-06-13 Tx date 2018-06-11	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-8,449 -7,100 vol $1.19 each	1,035,100
Filed 2018-06-13 Tx date 2018-06-08	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-22,800 -19,000 vol $1.20 each	1,042,200
Filed 2018-06-13 Tx date 2018-06-08	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,210 -1,000 vol $1.21 each	1,061,200
Filed 2018-06-13 Tx date 2018-06-08	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-13,640 -11,000 vol $1.24 each	1,062,200
Filed 2018-06-13 Tx date 2018-06-07	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-10,800 -10,000 vol $1.08 each	1,073,200
Filed 2018-06-13 Tx date 2018-06-06	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-12,285 -11,700 vol $1.05 each	1,083,200
Filed 2018-06-10 Tx date 2018-06-08	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-6,150 -5,000 vol $1.23 each	628,220
Filed 2018-06-10 Tx date 2018-06-07	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-5,700 -5,000 vol $1.14 each	633,220
Filed 2018-06-04 Tx date 2018-06-04	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Robert Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-3,300 -3,000 vol $1.10 each	4,541,613
Filed 2018-06-04 Tx date 2018-06-04	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Robert Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-3,360 -3,000 vol $1.12 each	4,535,613
Filed 2018-06-04 Tx date 2018-06-04	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Robert Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-3,330 -3,000 vol $1.11 each	4,538,613
Filed 2018-06-04 Tx date 2018-06-01	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Katherine 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-3,360 -3,000 vol $1.12 each	4,468,613
Filed 2018-06-04 Tx date 2018-06-01	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Katherine 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-3,300 -3,000 vol $1.10 each	4,471,613
Filed 2018-05-29 Tx date 2018-01-26	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$325,000 +500,000 vol $0.65 each	600,000
Filed 2018-05-23 Tx date 2018-05-22	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Katherine 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,910 -3,000 vol $0.97 each	4,474,613
Filed 2018-05-18 Tx date 2018-05-17	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Katherine 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,610 -3,000 vol $0.87 each	4,486,613
Filed 2018-05-18 Tx date 2018-05-18	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Katherine 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,850 -3,000 vol $0.95 each	4,477,613
Filed 2018-05-18 Tx date 2018-05-18	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Katherine 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,790 -3,000 vol $0.93 each	4,480,613
Filed 2018-05-18 Tx date 2018-05-17	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Katherine 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,700 -3,000 vol $0.90 each	4,483,613
Filed 2018-05-18 Tx date 2018-05-17	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Katherine 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,580 -3,000 vol $0.86 each	4,489,613
Filed 2018-05-16 Tx date 2018-05-10	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-5,280 -6,000 vol $0.88 each	1,108,200
Filed 2018-05-16 Tx date 2018-05-10	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-3,560 -4,000 vol $0.89 each	1,114,200
Filed 2018-05-09 Tx date 2018-05-07	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-5,220 -6,000 vol $0.87 each	1,128,200
Filed 2018-05-09 Tx date 2018-05-07	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,800 -2,000 vol $0.90 each	1,118,200
Filed 2018-05-09 Tx date 2018-05-07	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,670 -3,000 vol $0.89 each	1,120,200
Filed 2018-05-09 Tx date 2018-05-07	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-4,500 -5,000 vol $0.90 each	1,123,200
Filed 2018-05-01 Tx date 2018-04-26	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-11,250 -15,000 vol $0.75 each	1,134,200
Filed 2018-04-30 Tx date 2018-04-30	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Katherine 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,700 -3,000 vol $0.90 each	4,495,613
Filed 2018-04-30 Tx date 2018-04-30	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Katherine 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-3,000 -3,000 vol $1.00 each	4,492,613
Filed 2018-04-30 Tx date 2018-04-27	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Katherine 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,490 -3,000 vol $0.83 each	4,498,613
Filed 2018-04-23 Tx date 2018-04-19	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-710.00 -1,000 vol $0.71 each	1,168,200
Filed 2018-04-23 Tx date 2018-04-19	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,360 -2,000 vol $0.68 each	1,149,200
Filed 2018-04-23 Tx date 2018-04-19	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-9,315 -13,500 vol $0.69 each	1,151,200
Filed 2018-04-23 Tx date 2018-04-19	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,450 -3,500 vol $0.70 each	1,164,700
Filed 2018-04-19 Tx date 2018-04-19	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Katherine 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,250 -3,000 vol $0.75 each	4,501,613
Filed 2018-04-19 Tx date 2018-04-18	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Katherine 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,100 -3,000 vol $0.70 each	4,507,613
Filed 2018-04-19 Tx date 2018-04-19	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Katherine 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,190 -3,000 vol $0.73 each	4,504,613
Filed 2018-04-19 Tx date 2018-04-18	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-3,240 -4,500 vol $0.72 each	1,184,200
Filed 2018-04-19 Tx date 2018-04-18	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,840 -4,000 vol $0.71 each	1,180,200
Filed 2018-04-19 Tx date 2018-04-18	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-7,700 -11,000 vol $0.70 each	1,169,200
Filed 2018-04-12 Tx date 2018-04-10	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Katherine 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,250 -3,000 vol $0.75 each	4,510,613
Filed 2018-04-05 Tx date 2018-04-04	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-3,000 -5,000 vol $0.60 each	638,220
Filed 2018-04-05 Tx date 2018-03-28	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-5,022 -9,300 vol $0.54 each	1,188,700
Filed 2018-04-03 Tx date 2018-04-03	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-5,800 -10,000 vol $0.58 each	643,220
Filed 2018-03-27 Tx date 2018-03-27	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,750 -5,000 vol $0.55 each	653,220
Filed 2018-03-26 Tx date 2018-03-26	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,750 -5,000 vol $0.55 each	658,220
Filed 2018-03-22 Tx date 2018-03-21	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-8,670 -17,000 vol $0.51 each	1,201,000
Filed 2018-03-22 Tx date 2018-03-21	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,560 -3,000 vol $0.52 each	1,198,000
Filed 2018-02-26 Tx date 2017-09-25	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Options Stock Options 00 - Opening Balance-Initial SEDI Report		45,000
Filed 2018-02-16 Tx date 2018-02-08	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 00 - Opening Balance-Initial SEDI Report		700,000
Filed 2018-02-16 Tx date 2018-02-08	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Bath, Jennifer Lynne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2018-01-30 Tx date 2018-01-30	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,600 -5,000 vol $0.52 each	663,220
Filed 2018-01-29 Tx date 2018-01-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,600 -5,000 vol $0.52 each	668,220
Filed 2018-01-26 Tx date 2018-01-25	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Katherine 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,850 -5,000 vol $0.57 each	4,513,613
Filed 2018-01-26 Tx date 2018-01-24	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,385 -4,500 vol $0.53 each	1,218,000
Filed 2018-01-26 Tx date 2018-01-24	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-4,950 -9,000 vol $0.55 each	1,222,500
Filed 2018-01-26 Tx date 2018-01-24	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,890 -3,500 vol $0.54 each	1,231,500
Filed 2018-01-24 Tx date 2018-01-24	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Katherine 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,620 -3,000 vol $0.54 each	4,518,613
Filed 2018-01-11 Tx date 2018-01-09	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Katherine 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,065 -1,500 vol $0.71 each	4,526,113
Filed 2018-01-11 Tx date 2018-01-11	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Katherine 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,040 -3,000 vol $0.68 each	4,521,613
Filed 2018-01-11 Tx date 2018-01-10	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Katherine 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,065 -1,500 vol $0.71 each	4,524,613
Filed 2017-11-24 Tx date 2017-11-24	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	D'Orazio, Thomas 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-21,920 -40,000 vol $0.55 each	35,000
Filed 2017-11-23 Tx date 2017-11-20	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-350.00 -500 vol $0.70 each	1,235,000
Filed 2017-11-23 Tx date 2017-11-23	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	D'Orazio, Thomas 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-4,240 -8,000 vol $0.53 each	75,000
Filed 2017-11-23 Tx date 2017-11-20	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-10,005 -14,500 vol $0.69 each	1,235,500
Filed 2017-10-20 Tx date 2017-10-19	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Katherine 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-13,350 -15,000 vol $0.89 each	4,529,613
Filed 2017-10-20 Tx date 2017-10-19	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Katherine 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,720 -2,000 vol $0.86 each	4,527,613
Filed 2017-10-03 Tx date 2017-10-01	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Katherine 3 - 10% Security Holder of Issuer Direct Ownership	Options Stock Options 00 - Opening Balance-Initial SEDI Report		50,000
Filed 2017-10-03 Tx date 2017-10-01	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Katherine 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report		4,544,613
Filed 2017-09-28 Tx date 2017-09-25	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Hessing, Martin 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report		673,220
Filed 2017-09-25 Tx date 2017-09-18	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	beske, Oren 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Options Stock Options 50 - Grant of options	$505,000 +500,000 vol $1.01 each	500,000
Filed 2017-09-25 Tx date 2017-09-07	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	beske, Oren 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Options Stock Options 00 - Opening Balance-Initial SEDI Report
Filed 2017-09-21 Tx date 2017-07-01	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beniac, Reginald 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 00 - Opening Balance-Initial SEDI Report
Filed 2017-09-21 Tx date 2017-09-18	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beniac, Reginald 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	$303,000 +300,000 vol $1.01 each	300,000
Filed 2017-09-12 Tx date 2016-12-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Robert Patrick 5 - Senior Officer of Issuer Holder: Robert P Beecroft, Trustee for the Beecroft 2012 Family Trust (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report		329,320
Filed 2017-09-12 Tx date 2016-12-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Robert Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report		4,544,613
Filed 2017-09-12 Tx date 2016-12-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	D'Orazio, Thomas 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report		83,000
Filed 2017-09-12 Tx date 2017-08-16	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Wattie, Dawn 5 - Senior Officer of Issuer Direct Ownership	Common Shares 16 - Acquisition or disposition under a prospectus exemption	$35,000 +35,000 vol $1.00 each	35,000
Filed 2017-09-07 Tx date 2016-12-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Smith, Gregory Stuart 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report		50,000
Filed 2017-05-12 Tx date 2016-12-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Smith, Gregory Stuart 4 - Director of Issuer Holder: Kari Ridd (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report		5,000
Filed 2017-01-09 Tx date 2016-12-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Kuo, James 4 - Director of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	+150,000 vol	150,000
Filed 2017-01-09 Tx date 2016-12-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Kuo, James 4 - Director of Issuer Direct Ownership	Options Stock Options 00 - Opening Balance-Initial SEDI Report
Filed 2017-01-03 Tx date 2016-12-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Wattie, Dawn 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+250,000 vol	250,000
Filed 2017-01-03 Tx date 2016-12-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Robert Patrick 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 00 - Opening Balance-Initial SEDI Report
Filed 2017-01-03 Tx date 2016-12-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Wattie, Dawn 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+250,000 vol
Filed 2017-01-03 Tx date 2016-12-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Beecroft, Robert Patrick 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	+250,000 vol	250,000
Filed 2017-01-03 Tx date 2016-12-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Options Stock Options 00 - Opening Balance-Initial SEDI Report
Filed 2017-01-03 Tx date 2016-12-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	+100,000 vol	100,000
Filed 2017-01-03 Tx date 2016-12-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	D'Orazio, Thomas 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 00 - Opening Balance-Initial SEDI Report
Filed 2017-01-03 Tx date 2016-12-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	D'Orazio, Thomas 5 - Senior Officer of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	+500,000 vol	500,000
Filed 2017-01-03 Tx date 2016-12-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Smith, Gregory Stuart 4 - Director of Issuer Direct Ownership	Options Stock Options 00 - Opening Balance-Initial SEDI Report
Filed 2017-01-03 Tx date 2016-12-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Smith, Gregory Stuart 4 - Director of Issuer Direct Ownership	Options Stock Options 50 - Grant of options	+100,000 vol	100,000
Filed 2017-01-03 Tx date 2016-12-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Wattie, Dawn 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2016-12-30 Tx date 2016-12-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Champagne, Guy 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report		1,250,000
Filed 2016-12-30 Tx date 2016-12-29	$IPA ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.")	Wattie, Dawn 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report